Specialudgave på kroatisk: Kapitel 13 bind 034 s. 85 - 161
English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 32009L0002
Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)
Kommissionens direktiv 2009/2/EF af 15. januar 2009 om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (EØS-relevant tekst)
Kommissionens direktiv 2009/2/EF af 15. januar 2009 om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (EØS-relevant tekst)
EUT L 11 af 16.1.2009, p. 6–82
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) Dokumentet er offentliggjort i en specialudgave
(HR)
No longer in force, Date of end of validity: 31/05/2015; stiltiende ophævelse ved 32008R1272
Language
HTML
PDF
Official Journal
|
16.1.2009 |
DA |
Den Europæiske Unions Tidende |
L 11/6 |
KOMMISSIONENS DIREKTIV 2009/2/EF
af 15. januar 2009
om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer
(EØS-relevant tekst)
KOMMISSIONEN FOR DE EUROPÆISKE FÆLLESSKABER HAR —
under henvisning til traktaten om oprettelse af Det Europæiske Fællesskab,
under henvisning til Rådets direktiv 67/548/EØF af 27. juni 1967 om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (1), særlig artikel 28, og
ud fra følgende betragtninger:
|
(1) |
Artikel 4, stk. 3, i direktiv 67/548/EØF fastsætter kriterier og procedurer for harmonisering af klassificering og etikettering af stoffer. Punkt 4.1.3, 4.1.4 og 4.1.5 i bilag VI til direktiv 67/548/EØF pålægger virksomhederne så hurtigt som muligt at indlevere oplysninger til medlemsstaterne med forslag til harmoniseret klassificering og etikettering, når der fremkommer oplysninger, som taler for, at stoffet opfylder kriterierne for klassificering som mutagent, kræftfremkaldende eller reproduktionstoksisk. |
|
(2) |
Bilag I til direktiv 67/548/EØF indeholder en liste over farlige stoffer med angivelse af de enkelte stoffers klassificering og etikettering. Der er behov for ajourføring af denne liste ved, at der indsættes anmeldte nye stoffer og yderligere eksisterende stoffer, og at de allerede opførte stoffer tilpasses til den tekniske udvikling. Det er desuden nødvendigt, at visse stoffer udgår af listen. |
|
(3) |
I bilag I til direktiv 67/548/EØF er der allerede opført grupper af stoffer, især metalforbindelser, der er vurderet gruppevis og ved analogisering mellem stoffer. |
|
(4) |
I bilag I til direktiv 67/548/EØF er der ligeledes en række grupper, hvor de enkelte stoffer i gruppen er beskrevet, og hvor der til klassificeringen er benyttet grupperings- og analogiseringsprincipper, f.eks. mineraloliestrømme og gasser. |
|
(5) |
Det anføres i bilag VI til direktiv 67/548/EØF, at data, som er nødvendige for klassificering og etikettering, kan fremskaffes fra en række forskellige kilder, herunder resultaterne af validerede struktur/aktivitet-relationer og ekspertvurderinger. |
|
(6) |
Klassificeringen af nikkelforbindelserne i dette direktiv bygger på virkninger, der skyldes Ni2+-ionen, og foreliggende data for nikkelforbindelser. Klassificeringen bygger på en indplacering af nikkelforbindelser i grupper alt efter deres opløselighed i vand (f.eks. de uopløselige, de svagt opløselige og de opløselige nikkelforbindelser i hver sin gruppe). Vandopløseligheden er valgt som det første kriterium for afgrænsning af grupperne ud fra den begrundelse, at nikkelforbindelser med omtrent samme vandopløselighed vil føre til omtrent samme biotilgængelighed for Ni2+-ionerne og omtrent samme systemiske toksicitet. Det begrunder analogiseringen inden for grupperne fra stoffer, som foreliggende fyldestgørende testdata viser har en specifik virkning, til stoffer, der ikke findes sådanne testdata om. For nogle virkningers vedkommende er analogisering mellem grupperne velbegrundet, da omtrent samme virkninger er iagttaget for alle niveauer af vandopløselighed. Eksempelvis har epidemiologiske undersøgelser vist, at både opløselige og uopløselige nikkelforbindelser (i hver sin ende af opløselighedsskalaen) har lokale kræftfremkaldende virkninger i luftvejene. Der er derfor god grund til at konkludere, at svagt opløselige forbindelser (midt på skalaen) har lignende kræftfremkaldende egenskaber. |
|
(7) |
Ved den samlede vurdering af alle foreliggende oplysninger om nikkelforbindelser kan vandopløseligheden benyttes som tilnærmelse for Ni2+-ionens systemiske biotilgængelighed for mange virkningers og stoffers vedkommende. |
|
(8) |
Klassificeringen og etiketteringen af stoffer, som er opført i dette direktiv, bør tages op til fornyet overvejelse, hvis der fremkommer ny videnskabelig viden. Således bør især nikkelbranchens nylige fremlæggelse af foreløbige, ufuldstændige og ikke-fagfællebedømte oplysninger betyde, at resultaterne af de kommende drøftelser i WHO's Internationale Kræftforskningscenter af nikkelforbindelsers carcinogenicitet og alle nye relevante videnskabelige resultater eller fortolkninger af de data, der ligger til grund for klassificeringen af nikkelforbindelserne i dette direktiv, tillægges særlig betydning. |
|
(9) |
De i dette direktiv fastsatte foranstaltninger er i overensstemmelse med udtalelse fra Udvalget for Tilpasning til den Tekniske Udvikling af Direktiverne om Fjernelse af Tekniske Hindringer for Handelen med Farlige Stoffer og Præparater — |
UDSTEDT FØLGENDE DIREKTIV:
Artikel 1
I direktiv 67/548/EØF foretages følgende ændringer. I bilag I foretages følgende ændringer:
|
a) |
Stofferne, der svarer til stofferne i bilag 1A til dette direktiv, erstattes af stofferne i bilag 1A til dette direktiv. |
|
b) |
Stofferne i bilag 1B til dette direktiv indføjes i overensstemmelse med den rækkefølge, hvori stofferne er opført i bilag I til direktiv 67/548/EØF. |
|
c) |
Stofferne på listen i bilag 1C til dette direktiv udgår. |
Artikel 2
Medlemsstaterne sætter de nødvendige love og administrative bestemmelser i kraft for at efterkomme dette direktiv senest den 1. juni 2009. De tilsender straks Kommissionen disse bestemmelser med en sammenligningstabel, som viser sammenhængen mellem de pågældende bestemmelser og dette direktiv.
Disse bestemmelser skal ved vedtagelsen indeholde en henvisning til dette direktiv eller skal ved offentliggørelsen ledsages af en sådan henvisning. De nærmere regler for henvisningen fastsættes af medlemsstaterne.
Medlemsstaterne tilsender Kommissionen de vigtigste nationale bestemmelser, som de udsteder på det område, der er omfattet af dette direktiv.
Artikel 3
Dette direktiv træder i kraft på tyvendedagen efter offentliggørelsen i Den Europæiske Unions Tidende.
Artikel 4
Dette direktiv er rettet til medlemsstaterne.
Udfærdiget i Bruxelles, den 15. januar 2009.
På Kommissionens vegne
Stavros DIMAS
Medlem af Kommissionen
(1) EFT 196 af 16.8.1967, s. 1.
BILAG 1A
|
Indeksnr. |
Kemisk navn |
Noter vedrørende stoffer |
EF-nr. |
CAS-nr. |
Klassificering |
Etikettering |
Koncentrationsgrænser |
Noter vedrørende tilberedninger |
|
001-002-00-4 |
aluminiumlithiumhydrid |
|
240-877-9 |
16853-85-3 |
F; R15 C; R35 |
F; C R: 15-35 S: (1/2-)7/8-26-36/37/39-43-45 |
|
|
|
005-006-00-7 |
dibutyltinhydrogenborat |
E |
401-040-5 |
75113-37-0 |
Muta. Cat. 3; R68 Repr. Cat. 2; R60-61 T; R48/25 Xn; R21/22 Xi; R41 R43 N; R50-53 |
T; N R: 60-61-21/22-41-43-48/25-68-50/53 S: 53-45-60-61 |
|
|
|
006-007-00-5 |
salte af hydrogencyanid med undtagelse af komplekse salte som cyanoferrat (II) og-(III) og kviksølv(II)oxidcyanid |
A |
— |
— |
T+; R26/27/28 R32 N; R50-53 |
T+; N R: 26/27/28-32-50/53 S: (1/2-)7-28-29-45-60-61 |
|
|
|
006-015-00-9 |
diuron (ISO); 3-(3,4-dichlorphenyl)-1,1-dimethylurinstof |
|
206-354-4 |
330-54-1 |
Carc. Cat. 3; R40 Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-40-48/22-50/53 S: (2-)13-36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-40-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53 2,5 % ≤ C < 10 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
006-076-00-1 |
mancozeb (ISO); manganethylenbis(dithiocarbamat) (polymer), kompleks med zinksalt |
|
— |
8018-01-7 |
Repr. Cat. 3; R63 R43 N; R50 |
Xn; N R: 43-63-50 S: (2-)36/37-46-61 |
C ≥ 5 %: Xn, N; R43-63-50 2,5 ≤ C < 5 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
|
|
006-077-00-7 |
maneb (ISO); manganethylenbis(dithiocarbamat) (polymer) |
|
235-654-8 |
12427-38-2 |
Repr. Cat. 3; R63 Xn; R20 Xi; R36 R43 N; R50-53 |
Xn; N R: 20-36-43-63-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R20-36-43-63-50/53 20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53 5 % ≤ C < 20 %: Xn, N; R43-63-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
006-084-00-5 |
carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamat |
|
259-565-9 |
55285-14-8 |
T+; R26 T; R25 R43 N; R50-53 |
T+; N R: 25-26-43-50/53 S: (1/2-)28-36/37-38-45-63-60-61 |
|
|
|
006-088-00-7 |
benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninat |
|
— |
82560-54-1 |
Repr. Cat. 3; R62 T; R23 Xn; R22 N; R50-53 |
T; N R: 22-23-62-50/53 S: (1/2-)36/37-45-60-61 |
|
|
|
007-002-00-0 |
nitrogendioxid; [1] dinitrogentetraoxid [2] |
|
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
O; R8 T+; R26 C; R34 |
O; T+ R: 8-26-34 S: (1/2-)9-26-28-36/37/39-45 |
C ≥ 10 %: T+; R26-34 5 % ≤ C < 10 %: T; R23-34 1 % ≤ C < 5 %: T; R23-36/37/38 0,5 % ≤ C < 1 %: Xn; R20-36/37/38 0,1 % ≤ C < 0,5 %: Xn; R20 |
5 |
|
015-041-00-X |
malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethylphosphordithioat; [indeholdende ≤ 0,03 % isomalathion] |
|
204-497-7 |
121-75-5 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 1 % ≤ C < 25 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
|
015-100-00-X |
phoxim (ISO); α-(diethoxyphosphinothioylimino)phenylacetonitril |
|
238-887-3 |
14816-18-3 |
Repr. Cat. 3; R62 Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-62-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-62-50/53 5 % ≤ C < 25 %: Xn, N; R43-62-50/53 1 % ≤ C < 5 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
|
015-102-00-0 |
tris(2-chlorethyl)phosphat |
E |
204-118-5 |
115-96-8 |
Carc. Cat. 3; R40 Repr. Cat. 2; R60 Xn; R22 N; R51-53 |
T; N R: 60-22-40-51/53 S: 53-45-61 |
|
|
|
015-155-00-X |
glufosinat ammonium (ISO); ammonium-2-amino-4-(hydroxymethylphosphinyl)butyrat |
E |
278-636-5 |
77182-82-2 |
Repr. Cat. 2; R60 Repr. Cat. 3; R63 Xn; R20/21/22-48/20/22 |
T R: 60-20/21/22-48/20/22-63 S: 53-45 |
|
|
|
016-009-00-8 |
dinatriumsulfid; natriumsulfid |
|
215-211-5 |
1313-82-2 |
T; R24 Xn; R22 C; R34 R31 N; R50 |
T; C; N R: 22-24-31-34-50 S: (1/2-)26-36/37/39-45-61 |
|
|
|
017-009-00-0 |
ammoniumperchlorat; [indeholdende ≥ 80 % partikler på 0-30 μm] |
T |
232-235-1 |
7790-98-9 |
E; R3 O; R9 |
E R: 3-9 S: (2-)14-16-36/37 |
|
|
|
024-004-00-7 |
natriumdichromat |
E |
234-190-3 |
10588-01-9 |
O; R8 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 T+; R26 T; R25-48/23 Xn; R21 C; R34 R42/43 N; R50-53 |
O; T+; N R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53 S: 53-45-60-61 |
C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53 10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53 7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53 5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53 3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53 2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53 1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53 0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53 0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53 0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43 0,1 % ≤ C < 0,2 %: T; R45-46-20 |
3 |
|
027-002-00-4 |
cobaltoxid |
|
215-154-6 |
1307-96-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
027-003-00-X |
cobaltsulfid |
|
215-273-3 |
1317-42-6 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-60-61 |
C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
028-003-00-2 |
nikkelmonoxid; [1] nikkeloxid; [2] bunsenit [3] |
E |
215-215-7 [1] 234-323-5 [2] - [3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
|
028-004-00-8 |
nikkeldioxid |
E |
234-823-3 |
12035-36-8 |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
|
028-005-00-3 |
dinikkeltrioxid |
E |
215-217-8 |
1314-06-3 |
Carc. Cat. 1; R49 T; R48/23 R43 R53 |
T R: 49-43-48/23-53 S: 53-45-61 |
|
|
|
028-006-00-9 |
nikkel(II)sulfid; [1] nikkelsulfid; [2] millerit [3] |
E |
240-841-2 [1] 234-349-7 [2] - [3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 |
|
|
|
028-007-00-4 |
trinikkeldisulfid; nikkelsubsulfid; [1] heazlewoodit [2] |
E |
234-829-6 [1] - [2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 |
|
|
|
028-008-00-X |
nikkeldihydroxid; [1] nikkelhydroxid [2] |
E |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. Cat. 1; R49 Repr. Cat. 2; R61 Muta. Cat. 3; R68 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 |
T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 |
|
|
|
029-013-00-X |
trinatrium-(2-(α-(3-(4-chlor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenhydrazino)-4-sulfonatobenzoato)kobber(II) |
|
407-580-8 |
130201-51-3 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
033-005-00-1 |
arsensyre og dets salte undtagen sådanne nævnt andetsteds i dette bilag |
AE |
— |
— |
Carc. Cat. 1; R45 T; R23/25 N; R50-53 |
T; N R: 45-23/25-50/53 S: 53-45-60-61 |
|
|
|
034-002-00-8 |
selenforbindelser med undtagelse af cadmiumsulfoselenid (xCdS.yCdSe) undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
T; R23/25 R33 N; R50-53 |
T; N R: 23/25-33-50/53 S: (1/2-)20/21-28-45-60-61 |
|
|
|
047-001-00-2 |
sølvnitrat |
|
231-853-9 |
7761-88-8 |
O; R8 C; R34 N; R50-53 |
O; C; N R: 8-34-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
|
050-002-00-0 |
cyhexatin (ISO); hydroxytricyclohexylstannan; tri(cyclohexyl)tinhydroxid |
|
236-049-1 |
13121-70-5 |
Xn; R20/21/22 N; R50-53 |
Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 |
C ≥ 25 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 25 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
|
050-003-00-6 |
fentinacetat (ISO); triphenyltinacetat |
|
212-984-0 |
900-95-8 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 |
T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 |
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10% ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53. 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
|
|
050-004-00-1 |
fentinhydroxid (ISO); triphenyltinhydroxid |
|
200-990-6 |
76-87-9 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 |
T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 |
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
|
|
050-008-00-3 |
tributyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 |
T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 |
C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53 1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53 0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53 0,025 % C < 0,25 %: R52/53 |
1 |
|
050-011-00-X |
triphenyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
T; R23/24/25 N; R50-53 |
T; N R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 |
C ≥ 1 %: T, N; R23/24/25-50/53 0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
1 |
|
050-018-00-8 |
tin(II)methansulfonat |
|
401-640-7 |
53408-94-9 |
C; R34 Xn; R22 R43 N; R51-53 |
C; N R: 22-34-43-51/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
|
053-003-00-4 |
iodoxybenzen |
|
— |
696-33-3 |
E; R2 |
E R: 2 S: (2-)35 |
|
|
|
053-004-00-X |
calciumiodoxybenzoat |
C |
— |
— |
E; R2 |
E R: 2 S: (2-)35 |
|
|
|
080-001-00-0 |
kviksølv |
E |
231-106-7 |
7439-97-6 |
Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 |
T+; N R: 61-26-48/23-50/53 S: 53-45-60-61 |
|
|
|
080-010-00-X |
kviksølvdichlorid; kviksølvchlorid |
|
231-299-8 |
7487-94-7 |
Muta. Cat. 3; R68 Repr. Cat. 3; R62 T+; R28 T; R48/24/25 C; R34 N; R50-53 |
T+; N R: 28-34-48/24/25-62-68-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
|
092-002-00-3 |
uranforbindelser, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
T+; R26/28 R33 N; R51-53 |
T+; N R: 26/28-33-51/53 S: (1/2-)20/21-45-61 |
|
|
|
601-065-00-3 |
Blanding af: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran); (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran) |
|
416-930-9 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)36/37-61 |
|
|
|
602-007-00-X |
bromoform; tribrommethan |
|
200-854-6 |
75-25-2 |
T; R23 Xn; R22 Xi; R36/38 N; R51-53 |
T; N R: 22-23-36/38-51/53 S: (1/2-)28-45-63-61 |
|
|
|
602-030-00-5 |
1,3-dichlorpropen; [1] (Z)-1,3-dichlorpropen [2] |
C D |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
R10 T; R24/25 Xn; R20-65 Xi; R36/37/38 R43 N; R50-53 |
T; N R: 10-20-24/25-36/37/38-43-65-50/53 S: (1/2-)36/37-45-60-61 |
|
|
|
602-054-00-6 |
3-iodpropen; allyliodid |
|
209-130-4 |
556-56-9 |
F; R11 C; R34 |
F; C R: 11-34 S: (1/2-)7-16-26-45 |
|
|
|
603-005-00-1 |
2-methylpropan-2-ol; tert-butylalkohol |
|
200-889-7 |
75-65-0 |
F; R11 Xn; R20 Xi; R36/37 |
F; Xn R: 11-20-36/37 S: (2-)9-16-46 |
|
|
|
603-018-00-2 |
furfurylalkohol |
|
202-626-1 |
98-00-0 |
Carc. Cat. 3; R40 T; R23 Xn; R21/22-48/20 Xi; R36/37 |
T R: 21/22-23-36/37-40-48/20 S: (1/2-)36/37-45-63 |
|
|
|
603-023-00-X |
ethylenoxid; oxiran |
E |
200-849-9 |
75-21-8 |
F+; R12 R6 Carc. Cat. 2; R45 Muta. Cat. 2; R46 T; R23 Xi; R36/37/38 |
F+; T R: 45-46-6-12-23-36/37/38 S: 53-45 |
|
|
|
603-029-00-2 |
bis(2-chlorethyl)ether |
|
203-870-1 |
111-44-4 |
Carc. Cat. 3; R40 T+; R26/27/28 |
T+ R: 26/27/28-40 S: (1/2-)7/9-27-28-36/37-45 |
C ≥ 7 %: T+; R26/27/28-40 1 % ≤ C < 7 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
|
|
603-037-00-6 |
cellulosenitrat; nitrocellulose |
T |
— |
— |
E; R3 |
E R: 3 S: (2-)35 |
|
|
|
603-046-00-5 |
bis(chlormethyl)ether; oxybis(chlormethan) |
E |
208-832-8 |
542-88-1 |
F; R11 Carc. Cat. 1; R45 T+; R26 T; R24 Xn; R22 |
F; T+ R: 45-11-22-24-26 S: 53-45 |
C ≥ 25 %: T+; R45-22-24-26 7 % ≤ C < 25 %: T+; R45-21-26 3 % ≤ C < 7 %: T; R45-21-23 1 % ≤ C < 3 %: T; R45-23 0,1 % ≤ C < 1 %: T; R45-20 0,001 % ≤ C < 0,1 %: T; R45 |
|
|
603-064-00-3 |
1-methoxy-2-propanol; monopropylenglycolmethylether |
|
203-539-1 |
107-98-2 |
R10 R67 |
R: 10-67 S: (2-) |
|
|
|
603-066-00-4 |
1,2-epoxy-4-epoxyethylcyclohexan; 4-vinylcyclohexendiepoxid |
|
203-437-7 |
106-87-6 |
Carc. Cat. 3; R40 T; R23/24/25 |
T R: 23/24/25-40 S: (1/2-)36/37-45-63 |
C ≥ 1 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
|
|
605-004-00-1 |
2,4,6-trimethyl-1,3,5-trioxan; paraldehyd |
|
204-639-8 |
123-63-7 |
R10 |
R: 10 S: (2-)29 |
|
|
|
605-005-00-7 |
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctan; metaldehyd |
|
203-600-2 |
108-62-3 |
F; R11 Xn; R22 |
F; Xn R: 11-22 S: (2-)13-16-25-46 |
|
|
|
606-021-00-7 |
N-methyl-2-pyrrolidon; 1-methyl-2-pyrrolidon |
|
212-828-1 |
872-50-4 |
Repr. Cat. 2; R61 Xi; R36/37/38 |
T R: 61-36/37/38 S: 53-45 |
C ≥ 10 %: T; R61-36/37/38 5 % ≤ C < 10 %: T; R61 |
|
|
607-007-00-3 |
oxalsyrens salte undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
Xn; R21/22 |
Xn R: 21/22 S: (2-)24/25 |
C ≥ 5 %: Xn; R21/22 |
|
|
607-012-00-0 |
benzoylchlorid |
|
202-710-8 |
98-88-4 |
Xn; R20/21/22 C; R34 R43 |
C R: 20/21/22-34-43 S: (1/2-)26-36/37/39-45 |
|
|
|
607-037-00-7 |
2-ethoxyethylacetat; ethylglycolacetat |
E |
203-839-2 |
111-15-9 |
R10 Repr. Cat. 2; R60-61 Xn; R20/21/22 |
T R: 60-61-10-20/21/22 S: 53-45 |
|
|
|
607-051-00-3 |
MCPA (ISO); 4-chloro-o-tolyloxyeddikesyre |
|
202-360-6 |
94-74-6 |
Xn; R22 Xi; R38-41 N; R50-53 |
Xn; N R: 22-38-41-50/53 S: (2-)26-37-39-60-61 |
|
|
|
607-052-00-9 |
salte og estere af MCPA |
A |
— |
— |
Xn; R20/21/22 N; R50-53 |
Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 |
|
|
|
607-085-00-9 |
benzylbenzoat |
|
204-402-9 |
120-51-4 |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)25-46-61 |
|
|
|
607-095-00-3 |
maleinsyre |
|
203-742-5 |
110-16-7 |
Xn; R22 Xi; R36/37/38 R43 |
Xn R: 22-36/37/38-43 S: (2-)24-26-28-37-46 |
C ≥ 25 %: Xn; R22-36/37/38-43 20 % ≤ C <25 %: Xi; R36/37/38-43 0,1 % ≤ C < 20 %: Xi; R43 |
|
|
607-103-00-5 |
ravsyreanhydrid |
|
203-570-0 |
108-30-5 |
Xn; R22 Xi; R36/37 |
Xn R: 22-36/37 S: (2-)25-46 |
C ≥ 5 %: Xn; R22-36/37 1 % ≤ C < 5 %: Xi; R36/37 |
|
|
607-142-00-8 |
propylchlorformiat; chlormyresyrepropylester; n-propylchlorformiat |
|
203-687-7 |
109-61-5 |
F; R11 T; R23 C; R34 |
F; T R: 11-23-34 S: (1/2-)16-26-36-45 |
|
|
|
607-195-00-7 |
2-methoxy-1-methylethylacetat |
|
203-603-9 |
108-65-6 |
R10 |
R: 10 S: (2-) |
|
|
|
607-216-00-X |
glutaminsyre, reaktionsprodukter med N-(C12-14-alkyl)propylendiamin |
|
403-950-8 |
— |
T+; R26 Xn; R22 C; R34 N; R50 |
T+; N R: 22-26-34-50 S: (1/2-)26-36/37/39-38-45-61 |
|
|
|
607-231-00-1 |
clopyralid (ISO); 3,6-dichlorpyridin-2-carboxylsyre |
|
216-935-4 |
1702-17-6 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
607-245-00-8 |
tert-butylacrylat |
D |
216-768-7 |
1663-39-4 |
F; R11 Xn; R20/21/22 Xi; R37/38 R43 N; R51-53 |
F; Xn; N R: 11-20/21/22-37/38-43-51/53 S: (2-)16-25-37-61 |
C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53 20 % ≤ C < 25 %: Xi; R37/38-43-52/53 2,5 % ≤ C < 20 %: Xi; R43-52/53 1 % ≤ C < 2,5 %: Xi; R43 |
|
|
607-397-00-5 |
blanding af: Ca-salicylater (forgrenet C10-14- og C18-30-alkyleret); Ca-phenater (forgrenet C10-14- og C18-30-alkyleret); Ca-phenater, svovlbehandlede (forgrenet C10-14- og C18-30-alkyleret) |
|
415-930-6 |
— |
Repr. Cat. 3; R62 R43 |
Xn R: 43-62 S: (2-)23-36/37 |
|
|
|
608-005-00-5 |
n-butyronitril |
|
203-700-6 |
109-74-0 |
F; R11 T; R23/24/25 |
F; T R: 11-23/24/25 S: (1/2-)16-36/37-45-63 |
|
|
|
608-011-00-8 |
oxalonitril; cyanogen |
|
207-306-5 |
460-19-5 |
F+; R12 T; R23 N; R50-53 |
F+; T; N R: 12-23-50/53 S: (1/2-)9-16-23-33-45-63-60-61 |
|
|
|
608-044-00-8 |
2-cyclohexyliden-2-phenylacetonitril |
|
423-740-1 |
10461-98-0 |
Xn; R22 N; R51-53 |
Xn; N R; 22-51/53 S: (2-)46-61 |
|
|
|
609-007-00-9 |
2,4-dinitrotoluen; [1] dinitrotoluen [2] |
E |
204-450-0 [1] 246-836-1 [2] |
121-14-2 [1] 25321-14-6 [2] |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R23/24/25 Xn; R48/22 N; R50-53 |
T; N R: 45-23/24/25-48/22-62-68-50/53 S: 53-45-60-61 |
|
|
|
611-028-00-3 |
C,C′-azodi(formamid) |
|
204-650-8 |
123-77-3 |
E; R2 R42 |
E; Xn R: 2-42 S: (2-)22-24-37 |
|
|
|
611-035-00-1 |
tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalen-2,7-disulfonat |
|
403-660-1 |
107246-80-0 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
612-044-00-3 |
N,N′-diacetylbenzidin |
E |
210-338-2 |
613-35-4 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R20/21/22 |
T R: 45-20/21/22-68 S: 53-45 |
|
|
|
612-050-00-6 |
cyclohexylamin |
|
203-629-0 |
108-91-8 |
R10 Repr. Cat. 3; R62 Xn; R21/22 C; R34 |
C R: 10-21/22-34-62 S: (1/2-)26-36/37/39-45 |
C ≥ 25 %: C; R21/22-34-62 10 % ≤ C < 25 %: C; R34-62 5 % ≤ C < 10 %: Xn; R36/38-62 2% ≤ C < 5%: Xi; R36/38 |
|
|
612-076-00-8 |
ethyldimethylamin |
|
209-940-8 |
598-56-1 |
F; R11 Xn; R20/22 C; R34 |
F; C R: 11-20/22-34 S: (1/2-)3-16-26-36-45 |
|
|
|
612-099-00-3 |
4-methyl-m-phenylendiamin; 2,4-toluendiamin |
E |
202-453-1 |
95-80-7 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 R43 N; R51-53 |
T; N R: 45-21-25-43-48/22-62-68-51/53 S: 53-45-61 |
|
|
|
612-101-00-2 |
methenamin; hexamethylentetramin |
|
202-905-8 |
100-97-0 |
F; R11 R43 |
F; Xi R: 11-43 S: (2-)24-37 |
|
|
|
612-151-00-5 |
methyl-phenylendiamin; diaminotoluen; [teknisk produkt - blanding af 4-methyl-m-phenylendiamin (EF-nr. 202-453-1) og 2-methyl-m-phenylendiamin (EF-nr. 212-513-9)] |
E |
— |
— |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 Xi; R36 R43 N; R51-53 |
T; N R: 45-21-25-36-43-48/22-62-68-51/53 S: 53-45-61 |
|
|
|
612-237-00-2 |
hydroxylammoniumhydrogensulfat; hydroxylaminphosphat; [1] hydroxylamine phosphate; [2] hydroxylamindihydrogenphosphat; [3] hydroxylamin-4-methylbenzensulfonat [4] |
T |
233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] |
10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] |
E; R2 Carc. Cat. 3; R40 Xn; R21/22-48/22 Xi; R36/38 R43 N; R50 |
E; Xn; N R: 21/22-36/38-40-43-48/22-50 S: (2-)36/37-61 |
|
|
|
613-116-00-7 |
tolylfluanid (ISO); dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid; [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
|
211-986-9 |
731-27-1 |
T+; R26 T; R48/23 Xi; R36/37/38 R43 N; R50 |
T+; N R: 26-36/37/38-43-48/23-50 S: (1/2-)28-36/37/39-45-63-61 |
C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50 10 % ≤ C < 20 %: T+, N; R26-43-48/23-50 7 % ≤ C < 10 %: T+, N; R26-43-48/20-50 2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50 1 % ≤ C < 2,5 %: T; R23-43-48/20 0,1 % ≤ C < 1 %: Xn; R20 |
|
|
615-001-00-7 |
methylisocyanat |
|
210-866-3 |
624-83-9 |
F; R11 Repr. Cat. 3; R63 T+; R26 T; R24/25 R42/43 Xi; R37/38-41 |
F; T+ R: 11-24/25-26-37/38-41-42/43-63 S: (1/2-)16-26-27/28-36/37/39-45-63 |
|
|
|
615-004-00-3 |
salte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
Xn; R20/21/22 R32 R52-53 |
Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 |
|
|
|
615-028-00-4 |
ethyl-2-(isocyanatosulfonyl)benzoat |
|
410-220-2 |
77375-79-2 |
R14 Xn; R22-48/22 Xi; R41 R42/43 |
Xn R: 14-22-41-42/43-48/22 S: (2-)8-23-26-30-35-36/37/39 |
|
|
|
615-030-00-5 |
alkalisalte og jordalkalisalte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
Xn; R20/21/22 R32 R52-53 |
Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 |
|
|
|
615-031-00-0 |
thalliumthiocyanat |
|
222-571-7 |
3535-84-0 |
T+; R26/28 Xn; R21 R32 R33 N; R51-53 |
T+; N R: 21-26/28-32-33-51/53 S: (1/2-)13-28-36/37-45-61 |
|
|
|
615-032-00-6 |
metalsalt af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag |
A |
— |
— |
Xn; R20/21/22 R32 N; R50-53 |
Xn; N R: 20/21/22-32-50/53 S: (2-)13-36/37-46-60-61 |
|
|
|
616-124-00-9 |
lithium-bis(trifluormethylsulfonyl)imid |
|
415-300-0 |
90076-65-6 |
T; R24/25 Xn; R48/22 C; R34 R52-53 |
T R: 24/25-34-48/22-52/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
|
617-017-00-X |
blanding af: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzen; 2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzen |
T |
412-140-3 |
32144-25-5 |
E; R2 O; R7 R53 |
E R: 2-7-53 S: (2-)3/7-14-36/37/39-61 |
|
|
|
650-016-00-2 |
mineraluld, undtagen sådan nævnt andetsteds i dette bilag; [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)] |
AQR |
— |
— |
Carc. Cat. 3; R40 |
Xn R: 40 S: (2-)36/37 |
|
|
|
650-017-00-8 |
ildfaste keramiske fibre, specialfibre, undtagen sådanne nævnt andetsteds i dette bilag; [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+ MgO+BaO) over 18 % (w/w)] |
AR |
— |
— |
Carc. Cat. 2; R49 |
T R: 49 S: 53-45 |
|
|
BILAG 1B
|
Indeks nr. |
Kemisk navn |
Noter vedrørende stoffer |
EF-nr. |
CAS-nr. |
Klassificering |
Etikettering |
Koncentrationsgrænser |
Noter vedrørende tilberedninger |
|
003-003-00-5 |
(2-methylpropyl)lithium; isobutyllithium |
|
440-620-2 |
920-36-5 |
F; R15-17 R14 C; R35 R67 N; R50-53 |
F; C; N R: 14/15-17-35-67-50/53 S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 |
|
|
|
005-013-00-5 |
diethylmethoxyboran |
|
425-380-9 |
7397-46-8 |
F; R17 Xn; R20/21/22-48/22 C; R34 R43 R53 |
F; C R: 17-20/21/22-34-43-48/22-53 S: (1/2-)6-26-36/37/39-43-45-61 |
|
|
|
005-014-00-0 |
4-formylphenylboronsyre |
|
438-670-5 |
87199-17-5 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
005-017-00-7 |
natriumperborat; [1] perborsyre, natriumsalt; [2] perborsyre, natriumsalt, monohydrat; [3] natriumperoxometaborat; [4] perborsyre (HBO(O2)), natriumsalt, monohydrat; [5] natriumperoxoborat; [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
E |
239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] |
15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] |
O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R22 Xi; R37-41 |
O; T R: 61-8-22-37-41-62 S: 53-45 |
C ≥ 25 %: T; R61-22-37-41-62 22 % ≤ C < 25 %: T; R61-37-41-62 20 % ≤ C < 22 %: T; R61-36/37-62 14 % ≤ C < 20 %: T; R61-36-62 9 % ≤ C < 14 %: T; R61-62 6,5 % ≤ C < 9 %: T; R61 |
|
|
005-017-01-4 |
natriumperborat; [1] perborsyre, natriumsalt; [2] perborsyre, natriumsalt, monohydrat; [3] natriumperoxometaborat; [4] perborsyre (HBO(O2)), natriumsalt, monohydrat; [5] natriumperoxoborat; [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
E |
239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] |
15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] |
O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T; R23 Xn; R22 Xi; R37-41 |
O; T R: 61-8-22-23-37-41-62 S: 53-45 |
C ≥ 25 %: T; R61-22-23-37-41-62 22 % ≤ C < 25 %: T; R61-20-37-41-62 20 % ≤ C < 22 %: T; R61-20-36/37-62 14 % ≤ C < 20 %: T; R61-20-36-62 9 % ≤ C < 14 %: T; R61-20-62 6,5 % ≤ C < 9 %: T; R61-20 3 % ≤ C < 6,5 %: Xn; R20 |
|
|
005-018-00-2 |
perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1] perborsyre, natriumsalt, tetrahydrat; [2] perborsyre (HBO(O2)), natriumsalt tetrahydrat; [3] natriumperoxoborathexahydrat; [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
|
- [1] - [2] - [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R37-41 |
T R: 61-37-41-62 S: 53-45-47 |
C ≥ 36 %: T; R61-37-41-62 22 % ≤ C < 36 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
|
|
005-018-01-X |
perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1] perborsyre, natriumsalt, tetrahydrat; [2] perborsyre (HBO(O2)), natriumsalt, tetrahydrat; [3] natriumperoxoborathexahydrat; [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
E |
- [1] - [2] - [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R20 Xi; R37-41 |
T R: 61-20-37-41-62 S: 53-45-47 |
C ≥ 36 %: T; R61-20-37-41-62 25 % ≤ C < 36 %: T; R61-20-36/37-62 22 % ≤ C < 25 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
|
|
006-097-00-6 |
1-phenyl-3-(p-toluensulfonyl)urinstof |
|
424-620-1 |
13909-63-2 |
Xn; R22-48/22 R52-53 |
Xn R: 22-48/22-52/53 S: (2-)22-36-61 |
|
|
|
006-098-00-1 |
tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamat |
|
429-170-8 |
134575-17-0 |
Xn; R22-48/22 Xi; R41 R43 |
Xn R: 22-41-43-48/22 S: (2-)22-26-36/37/39 |
|
|
|
006-099-00-7 |
N-(p-toluensulfonyl)-N′-(3-(p-toluensulfonyloxy)phenyl)urinstof; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzensulfonat |
|
432-520-2 |
232938-43-1 |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
|
006-101-00-6 |
blanding af: N,N″-(methylendi-4,1-phenylen)bis[N′-phenylurinstof]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurinstof; N,N″-(methylendi-4,1-phenylen)bis[N′-cyclohexylurinstof] |
|
423-070-8 |
— |
R53 |
R: 53 S: 61 |
|
|
|
006-102-00-1 |
O-hexyl-N-ethoxycarbonylthiocarbamat |
E |
432-750-3 |
— |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R22-48/22 R43 N; R51-53 |
T; N R: 45-46-22-43-48/22-51/53 S: 53-45-61 |
|
|
|
006-103-00-7 |
N,N″-(methylendi-4,1-phenylen)bis[N′-octyl]urinstof |
|
445-760-8 |
— |
Xi; R41 R42 N; R50-53 |
Xn; N R: 41-42-50/53 S: (2-)22-26-39-45-60-61 |
C ≥10 %: Xn, N; R41-42-50/53 5 % ≤ C < 10 %: Xn, N; R36-42-50/53 1 % ≤ C < 5 %: Xn, N; R42-50/53 0,25 % ≤ C < 1 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 ≤ C < 0,025 %: R52/53 |
|
|
007-029-00-8 |
diethyldimethylammoniumhydroxid |
|
419-400-5 |
95500-19-9 |
Xn; R21/22 C; R35 |
C R: 21/22-35 S: (1/2-)26-36/37/39-45 |
|
|
|
012-004-00-X |
aluminium-magnesium-carbonat-hydroxid-perchlorat-hydrat |
|
422-150-1 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
014-036-00-X |
(4-ethoxyphenyl)(3-(4-fluor-3-phenoxyphenyl)propyl)dimethylsilan |
|
405-020-7 |
105024-66-6 |
Repr.Cat.2; R60 N; R50-53 |
T; N R: 60-50/53 S: 53-45-60-61 |
C ≥ 0,5 %: T, N; R60-50/53 0,025 % ≤ C < 0,5 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
|
|
014-037-00-5 |
2-butanon-O,O′,O′′-(phenylsilylidyn)trioxim |
|
433-360-6 |
34036-80-1 |
Xn; R48/22 R43 R52-53 |
Xn R: 43-48/22-52/53 S: (2-)36/37-61 |
|
|
|
014-038-00-0 |
S-(3-(triethoxysilyl)propyl)octanthioat |
|
436-690-9 |
220727-26-4 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
014-039-00-6 |
(2,3-dimethylbut-2-yl)-trimethoxysilan |
|
439-360-2 |
142877-45-0 |
Xi; R38-41 R52-53 |
Xi R: 38-41-52/53 S: (2-)26-37/39-61 |
|
|
|
014-041-00-7 |
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilan |
|
445-890-5 |
201290-01-9 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)24-37 |
|
|
|
014-042-00-2 |
blanding af: O,O′,O″,O‴-silantetrayl-tetrakis(4-methyl-2-pentanonoxim) (3 stereoisomerer) |
|
423-010-0 |
— |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
014-043-00-8 |
reaktionsprodukt mellem amorf silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraethylorthosilicat (5-15 %) og titantetrachlorid (5-20 %) |
|
432-200-2 |
— |
F; R11 Xi; R37/38-41 R52-53 |
F; Xi R: 11-37/38-41-52/53 S: (2-)6-26-36/39-61 |
|
|
|
014-044-00-3 |
3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilan |
|
433-050-0 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
014-045-00-9 |
magnesiumnatriumfluoridsilicat |
|
442-650-1 |
— |
Xn; R48/20 |
Xn R: 48/20 S: (2-)22-36 |
|
|
|
015-190-00-0 |
bis(2,4-dicumylphenyl)neopentyldiphosphit; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan |
|
421-920-2 |
154862-43-8 |
R53 |
R: 53 S: 61 |
|
|
|
015-191-00-6 |
dodecyldiphenylphosphat |
|
431-760-5 |
27460-02-2 |
Xi; R38 R52-53 |
Xi R: 38-52/53 S: (2-)37-61 |
|
|
|
015-192-00-1 |
tetrakis(2,6-dimethylphenyl)-m-phenylenbiphosphat |
|
432-770-2 |
139189-30-3 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
015-193-00-7 |
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butansulfonamid (1:1) |
|
442-960-7 |
332350-93-3 |
T; R25 Xi; R41 N; R50-53 |
T; N R: 25-41-50/53 S: (1/2-)26-39-45-60-61 |
|
|
|
015-194-00-2 |
tetrabutylphosphonium-nonafluorbutan-1-sulfonat |
|
444-440-5 |
220689-12-3 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)61 |
|
|
|
015-195-00-8 |
blanding af: kalium-o-toluenphosphonat; kalium-m-toluenphosphonat; kalium-p-toluenphosphonat |
|
433-860-4 |
— |
Xi; R36 R43 R52-53 |
Xi R: 36-43-52/53 S: (2-)24-26-37-61 |
|
|
|
015-196-00-3 |
blanding af: dimethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat; diethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat; methylethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat |
|
435-960-3 |
— |
Carc.Cat.2; R45 Muta.Cat.2; R46 R43 |
T R: 45-46-43 S: 53-45 |
|
|
|
015-197-00-9 |
bis(2,4,4-trimethylpentyl)dithiophosphonsyre |
|
420-160-9 |
107667-02-7 |
R10 T; R23 Xn; R22 C; R34 N; R51-53 |
T; N R: 10-22-23-34-51/53 S: (1/2-)9-26-36/37/39-45-61 |
|
|
|
015-198-00-4 |
(4-phenylbutyl)phosphinsyre |
|
420-450-5 |
86552-32-1 |
Carc.Cat.3; R40 Xi; R41 |
Xn R: 40-41 S: (2-)23-26-36/37/39 |
|
|
|
016-094-00-1 |
svovl |
|
231-722-6 |
7704-34-9 |
Xi; R38 |
Xi R: 38 S: (2-)46 |
|
|
|
016-097-00-8 |
1-amino-2-methyl-2-propanthiolhydrochlorid |
|
434-480-1 |
32047-53-3 |
Xn; R22 C; R34 R43 R52-53 |
C R: 22-34-43-52/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
|
017-009-01-8 |
ammoniumperchlorat; [indeholdende < 80 % partikler på 0-30 μm] |
T |
232-235-1 |
7790-98-9 |
E; R2 O; R9 |
E R: 2-9 S: (2-)14-16-36/37 |
|
|
|
022-004-00-1 |
kaliumtitanoxid (K2Ti6O13) |
|
432-240-0 |
12056-51-8 |
Carc.Cat.3; R40 |
Xn R: 40 S: (2-)22-36/37 |
|
|
|
022-005-00-7 |
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadien]-titan |
|
419-840-8 |
169104-71-6 |
F; R11 C; R34 R43 R53 |
F; C R: 11-34-43-53 S: (1/2-)6-9-16-26-36/37/39-45-61 |
|
|
|
028-002-01-4 |
nikkelpulver; [partikeldiameter < 1 mm] |
|
231-111-4 |
7440-02-0 |
Carc. Cat. 3; R40 T; R48/23 R43 R52-53 |
T R: 40-43-48/23-52/53 S: (2-)36/37/39-45-61 |
|
|
|
028-013-00-7 |
nikkelsten |
E, H |
273-749-6 |
69012-50-6 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-014-00-2 |
mudder og slam, kobberraffineringselektrolyse-, renset for kobber, nikkelsulfat |
E |
295-859-3 |
92129-57-2 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 |
T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53 20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53 2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-015-00-8 |
mudder og slam, kobberraffineringselektrolyse-, renset for kobber |
E, H |
305-433-1 |
94551-87-8 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 1; R61 Repr. Cat. 3; R62 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-62-68-50/53 S: 53-45-60-61 |
|
|
|
028-016-00-3 |
nikkeldiperchlorat; perchlorsyre, nikkel(II)salt |
E, H |
237-124-1 |
13637-71-3 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 C; R34 R42/43 N; R50-53 |
T; N R: 49-61-34-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53 5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-017-00-9 |
nikkeldikaliumbis(sulfat); [1] diammoniumnikkelbis(sulfat) [2] |
E, H |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 |
T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-018-00-4 |
nikkelbis(sulfamidat); nikkelsulfamat |
E, H |
237-396-1 |
13770-89-3 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-019-00-X |
nikkelbis(tetrafluorborat) |
E, H |
238-753-4 |
14708-14-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-021-00-0 |
nikkeldiformat; [1] myresyre, nikkelsalt; [2] myresyre, kobbernikkkelsalt [3] |
E, H |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
|
|
028-022-00-6 |
nikkeldi(acetat); [1] nikkelacetat [2] |
E, H |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 |
T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-024-00-7 |
nikkeldibenzoat |
E, H |
209-046-8 |
553-71-9 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-025-00-2 |
nikkelbis(4-cyclohexylbutyrat) |
E, H |
223-463-2 |
3906-55-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-026-00-8 |
nikkel(II)stearat; nikkel(II)octadecanoat |
E, H |
218-744-1 |
2223-95-2 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-027-00-3 |
nikkeldilactat |
E, H |
— |
16039-61-5 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-028-00-9 |
nikkel(II)octanoat |
E, H |
225-656-7 |
4995-91-9 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat 2; R61 T; R48/23 C; R35 R42/43 N; R50-53 |
T; C; N R: 49-61-35-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53 10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53 5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-029-00-4 |
nikkeldifluorid; [1] nikkeldibromid; [2] nikkeldiiodid; [3] nikkelkaliumfluorid [4] |
E, H |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-030-00-X |
nikkelhexafluorsilicat |
E, H |
247-430-7 |
26043-11-8 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-031-00-5 |
nikkelselenat |
E, H |
239-125-2 |
15060-62-5 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-032-00-0 |
nikkelhydrogenphosphat; [1] nikkelbis(dihydrogenphosphat); [2] trinikkelbis(orthophosphat); [3] dinikkeldiphosphat; [4] nikkelbis(phosphinat); [5] nikkelphosphinat; [6] phosphorsyre, calciumnikkelsalt;[7] diphosphorsyyre, nikkel(II)salt [8] |
E, H |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-033-00-6 |
diammoniumnikkelhexacyanoferrat |
E, H |
— |
74195-78-1 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-034-00-1 |
nikkeldicyanid |
E, H |
209-160-8 |
557-19-7 |
Carc. Cat. 1; R49 T; R48/23 R42/43 R32 N; R50-53 |
T; N R: 49-32-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-035-00-7 |
nikkelchromat |
E, H |
238-766-5 |
14721-18-7 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-036-00-2 |
nikkel(II)silicat; [1] dinikkelorthosilicat; [2] nikkelsilicat (3:4); [3] kiselsyre, nikkelsalt; [4] trihydrogenhydroxybis[orthosilicato(4-)]trinikkelat(3-) [5] |
E, H |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-037-00-8 |
dinikkelhexacyanoferrat |
E, H |
238-946-3 |
14874-78-3 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-038-00-3 |
trinikkel bis(arsenat); nikkel(II)arsenat |
E, H |
236-771-7 |
13477-70-8 |
Carc. Cat. 1; R45 T; R48/23 R43 N; R50-53 |
T; N R: 45-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-039-00-9 |
nikkeloxalat; [1] oxalsyre, nikkelsalt [2] |
E, H |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. Cat. 1; R49 T; R48/23 R43 N: R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-040-00-4 |
nikkeltellurid |
E, H |
235-260-6 |
12142-88-0 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-041-00-X |
trinikkeltetrasulfid |
E, H |
— |
12137-12-1 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-042-00-5 |
trinikkelbis(arsenit) |
E, H |
— |
74646-29-0 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-043-00-0 |
cobaltnikkelgrå periclas; C.I. Pigment Black 25; C.I. 77332; [1] cobaltnikkeldioxid; [2] cobaltnikkeloxid [3] |
E, H |
269-051-6 [1] 261-346-8 [2] - [3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
|
028-044-00-6 |
nikkeltintrioxid; nikkelstannat |
E, H |
234-824-9 |
12035-38-0 |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
|
028-045-00-1 |
nikkeltriurandecaoxid |
E, H |
239-876-6 |
15780-33-3 |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
|
028-046-00-7 |
nikkeldithiocyanat |
E, H |
237-205-1 |
13689-92-4 |
Carc. Cat. 1; R49 Muta. Cat. 3;R68 Repr. Cat. 2; R61 T; R48/23 R42/43 R32 N; R50-53 |
T; N R: 49-61-32-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-047-00-2 |
nikkeldichromat |
E, H |
239-646-5 |
15586-38-6 |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
|
|
028-048-00-8 |
nikkel(II)selenit |
E, H |
233-263-7 |
10101-96-9 |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-049-00-3 |
nikkelselenid |
E, H |
215-216-2 |
1314-05-2 |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-050-00-9 |
kiselsyre, blynikkelsalt |
E, H |
— |
68130-19-8 |
Carc. Cat. 1: R49 Repr. Cat. 1: R61 Repr. Cat. 3; R62 T; R48/23 R43 N; R50-53 |
T; N R: 49-61-43-48/23-62-50/53 S: 53-45-60-61 |
|
|
|
028-051-00-4 |
nikkeldiarsenid; [1] nikkelarsenid [2] |
E, H |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-052-00-X |
nikkelbariumtitanprimulagul priderit; C.I. Pigment Yellow 157; C.I. 77900 |
E, H |
271-853-6 |
68610-24-2 |
Carc. Cat. 1: R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
|
028-053-00-5 |
nikkeldichlorat; [1] nikkeldibromat; [2] ethylhydrogensulfat, nikkel(II)salt [3] |
E, H |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T: R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-054-00-0 |
nikkel(II)trifluoracetat; [1] nikkel(II)propionat; [2] nikkelbis(benzensulfonat); [3] nikkel(II)hydrogencitrat; [4] citronsyre, ammoniumnikkelsalt; [5] citronsyre, nikkelsalt; [6] nikkelbis(2-ethylhexanoat); [7] 2-ethylhexansyre, nikkelsalt; [8] dimethylhexansyre, nikkelsalt; [9] nikkel(II)isooctanoat; [10] nikkelisooctanoat; [11] nikkelbis(isononanoat); [12] nikkel(II)neononanoat; [13] nikkel(II)isodecanoat; [14] nikkel(II)neodecanoat; [15] neodecansyre, nikkelsalt; [16] nikkel(II)neoundecanoat; [17] bis(D-gluconato-O 1,O 2)nikkel; [18] nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoat (1:2); [19] nikkel(II)palmitat; [20] (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21] (isononanoato-O)(isooctanoato-O)nikkel; [22] (isooctanoato-O)(neodecanoato-O)nikkel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25] (isodecanoato-O)(isooctanoato-O)nikkel; [26] (isodecanoato-O)(isononanoato-O)nikkel; [27] (isononanoato-O)(neodecanoato-O)nikkel; [28] fedtsyrer, C6-19-forgrenede, nikkelsalte; [29] fedtsyrer, C8-18 og C18-umættede, nikkelsalte; [30] 2,7-naphthalendisulfonsyre, nikkel(II)salt; [31] |
E, H |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 |
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
|
|
028-055-00-6 |
nikkel(II)sulfit; [1] nikkeltellurtrioxid; [2] nikkeltellurtetraoxid; [3] molybdennikkelhydroxidoxidphosphat [4] |
E, H |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 |
T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-056-00-1 |
nikkelborid (NiB); [1] dinikkelborid; [2] trinikkelborid; [3] nikkelborid; [4] dinikkelsilicid; [5] nikkeldisilicid; [6] dinikkelphosphid; [7] nikkelborphosphid [8] |
E, H |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 |
T; N R: 49-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
028-057-00-7 |
dialuminiumnikkeltetraoxid; [1] nikkeltitantrioxid; [2] nikkeltitanoxid; [3] nikkeldivanadiumhexaoxid; [4] cobaltdimolybdennikkeloctaoxid; [5] nikkelzirkoniumtrioxid; [6] molybdennikkeltetraoxid; [7] nikkelwolframtetraoxid; [8] olivin, nikkelgrøn; [9] lithiumnikkeldioxid; [10] molybdennikkeloxid; [11] |
E, H |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. Cat. 1; R49 T; R48/23 R43 |
T R: 49-43-48/23 S: 53-45 |
|
|
|
028-058-00-2 |
cobaltlithiumnikkeloxid |
E |
442-750-5 |
— |
Carc. Cat. 1; R49 T+; R26 T; R48/23 R43 N; R50-53 |
T+; N R: 49-26-43-48/23-50/53 S: 53-45-60-61 |
|
|
|
029-014-00-5 |
blanding af: 2,2′-[[cis-1,2-cyclohexandiylbis(nitrilomethyliden)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks; 2,2′-[[trans-1,2-cyclohexandiylbis(nitrilomethylidyn)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks |
|
419-610-7 |
171866-24-3 |
Xn; R48/22 N; R51-53 |
Xn; N R: 48/22-51/53 S: (2-)22-36-61 |
|
|
|
030-012-00-1 |
aluminium-magnesium-zink-carbonat-hydroxid |
|
423-570-6 |
169314-88-9 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
030-015-00-8 |
tetrazink(2+)-bis(hexacyanocobalt(3+))diacetat |
|
440-060-9 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
042-005-00-0 |
blanding af: mono-og di-glyceroler af rapsolie; rapsoliefedtsyreamid af forgrenet 1,3-propandiamin, N-[3-(tridecyloxy)-propyl]-; N,N-diorgano-dithiocarbamat molybdenkompleks-diorgano dithiocarbamate molybdenum complex |
|
434-240-6 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
|
050-023-00-5 |
blanding af: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannan; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxid; bis(1-phenyl-1,3-decandionyl)dioctylstannan; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decandionyl)dioctylstannan |
|
422-920-5 |
— |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)23-36-60-61 |
C ≥ 10 %: Xn, N; R48/22-50/53 2,5 % ≤ C < 10 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
050-024-00-0 |
blanding af: tri-p-tolyltinhydroxid; hexa-p-tolyl-distannoxan |
|
432-230-6 |
— |
T; R48/25 Xn; R22 Xi; R38-41 R43 N; R50-53 |
T; N R: 22-38-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 |
|
|
|
064-001-00-8 |
gadolinium(III)sulfittrihydrat |
|
456-900-2 |
51285-81-5 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
078-011-00-5 |
hydroxydisulfitoplatin(II)syre |
|
423-310-1 |
61420-92-6 |
Xn; R22-48/20/21/22 C; R35 R42/43 R52-53 |
C R: 22-35-42/43-48/20/21/22-52/53 S: (1/2-)23-24-26-28-36/37/39-45-61 |
|
|
|
078-012-00-0 |
platin(IV)nitrat/salpetersyreopløsning |
|
432-400-1 |
— |
C; R35 N; R50-53 |
C; N R: 35-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
|
082-012-00-6 |
barium-bly-calcium-caesium-samarium-strontium-bromid-chlorid-fluorid-iodid, europium-doteret |
|
431-780-4 |
199876-46-5 |
Xn; R22-48/22 N; R51-53 |
Xn; N R: 22-48/22-51/53 S: (2-)22-36-61 |
|
|
|
601-080-00-5 |
blanding af: sec-butylphenyl(phenyl)methan, blandede isomerer; 1-(sec-butylphenyl(phenyl)-2-phenylethan, blandede isomerer; 1-(sec-butylphenyl-1-phenylethan, blandede isomerer |
|
431-100-6 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
601-081-00-0 |
cyclohexadeca-1,9-dien |
|
431-730-1 |
4277-06-9 |
Xi; R38 R43 R53 |
Xi R: 38-43-53 S: (2-)36/37-61 |
|
|
|
601-082-00-6 |
blanding af: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan |
|
434-420-4 |
— |
Xi; R38-41 N; R50-53 |
Xi; N R: 38-41-50/53 S: (2-)23-26-37/39-57-60-61 |
|
|
|
601-083-00-1 |
5-endo-hexyl-bicyclo[2.2.1]hept-2-en |
|
435-000-3 |
22094-83-3 |
Xn; R65 Xi; R38 R53 |
Xn R: 38-65-53 S: (2-)37-62-61 |
|
|
|
601-084-00-7 |
blanding af: 5-endo-butyl-bicyclo[2.2.1]hept-2-en; 5-exo-butyl-bicyclo[2.2.1]hept-2-en (80:20) |
|
435-180-3 |
— |
Xn; R65 Xi; R38 N; R50-53 |
Xn; N R: 38-65-50/53 S: (2-)37-62-60-61 |
|
|
|
602-105-00-2 |
natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butansulfinat |
|
422-100-7 |
102061-82-5 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
|
602-106-00-8 |
2-brom-4,6-difluoranilin |
|
429-430-0 |
444-14-4 |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)25-61 |
|
|
|
602-107-00-3 |
3,3,4,4-tetrafluor-4-iod-1-buten |
|
439-500-2 |
33831-83-3 |
Xn; R22 Xi; R38 N; R51-53 |
Xn; N R: 22-38-51/53 S: (2-)37-61 |
|
|
|
602-108-00-9 |
(2,3,5,6-tetrafluorphenyl)methanol |
|
443-840-7 |
4084-38-2 |
Xn; R22 Xi; R36 R43 |
Xn R: 22-36-43 S: (2-)26-36/37 |
|
|
|
603-211-00-1 |
2,3-epoxypropyltrimethylammoniumchlorid …%; glycidyltrimethylammoniumchlorid …% |
B E |
221-221-0 |
3033-77-0 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 Xn; R21/22-48/22 Xi; R41 R43 R52-53 |
T R: 45-21/22-41-43-48/22-62-68-52/53 S: 53-45-61 |
|
|
|
603-212-00-7 |
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolid; (HHCB) |
|
214-946-9 |
1222-05-5 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
603-213-00-2 |
2-methoxy-2-methylbutan; tert-amylmethylether |
|
213-611-4 |
994-05-8 |
F; R11 Xn; R22 R67 |
F; Xn R: 11-22-67 S: (2-)9-16-23-33 |
|
|
|
603-214-00-8 |
1,1-diisopropoxycyclohexan |
|
413-740-8 |
1132-95-2 |
C; R34 |
C R: 34 S: (1/2-)23-26-36/37/39-45 |
|
|
|
603-215-00-3 |
1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octan-bis(tetrafluorborat) |
|
418-330-2 |
162241-33-0 |
E; R2 Xn; R22-48/22 Xi; R41 R43 N; R50-53 |
E; Xn; N R: 2-22-41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
|
603-216-00-9 |
cis-1-amino-2,3-dihydro-1H-inden-2-ol |
|
422-660-2 |
7480-35-5 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 |
|
|
|
603-217-00-4 |
2,4,6-tri-tert-butylphenyl-2-butyl-2-ethyl-1,3-propandiolphosphit |
|
423-560-1 |
161717-32-4 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37/39-61 |
|
|
|
603-220-00-0 |
1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol |
|
432-890-5 |
72955-94-3 |
R53 |
R: 53 S: 61 |
|
|
|
603-221-00-6 |
1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende < 0,1 % 4-chloranilin (EF-nr. 203-401-0)] |
|
433-580-2 |
214353-17-0 |
Xn; R22 C; R34 N; R51-53 |
C; N R: 22-34-51/53 S: (1/2-)26-36/37/39-45-61 |
|
|
|
603-221-01-3 |
1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende ≥ 0,1 % 4-chloranilin (EF-nr. 203-401-0)] |
E |
433-580-2 |
214353-17-0 |
Carc. Cat. 2; R45 Xn; R22 C; R34 N; R51-53 |
T; N R: 45-22-34-51/53 S: 53-45-61 |
|
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecan |
|
433-820-6 |
118058-74-5 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
|
603-223-00-7 |
2-cyclopentylidencyclopentanol; 1,1′-bi(cyclopentyliden)-2-ol |
|
434-270-1 |
6261-30-9 |
Xi; R38-41 R52-53 |
Xi R: 38-41-52/53 S: (2-)26-37/39-61 |
|
|
|
603-224-00-2 |
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)-hexan |
|
435-790-1 |
297730-93-9 |
R53 |
R: 53 S: 61 |
|
|
|
603-225-00-8 |
erythromycin A9-oxim (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E) |
|
437-070-0 |
13127-18-9 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
603-226-00-3 |
4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzen-1,3-diol |
|
444-500-0 |
1440-00-2 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
603-227-00-9 |
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]ether med 2,2-bis(hydroxymethyl)-1,3-propandiol (4:1); reaktionsprodukt af α-hydro-ω-((chlorcarbonyl)oxy)-poly(oxy(methyl-1,2-ethandiyl))ether med 2,2-bis(hydroxymethyl)-1,3-propandiol og kalium-1,1-dimethylethylperoxalat |
|
445-060-2 |
203574-04-3 |
O; R7 N; R50-53 |
O; N R: 7-50/53 S: (2-)3/7-14-36/37/39-60-61 |
|
|
|
603-228-00-4 |
(+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluor-2-(2-oxiranyl)chroman |
|
419-620-1 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)36/37-61 |
|
|
|
603-229-00-X |
natrium-(Z)-3-chlor-3-(4-chlorphenyl)-1-hydroxy-2-propen-1-sulfonat |
|
420-800-7 |
— |
Xi; R38-41 R43 N; R50-53 |
Xi; N R: 38-41-43-50/53 S: (2-)24-26-37/39-60-61 |
|
|
|
603-230-00-5 |
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan |
|
440-030-5 |
— |
Xi; R38-41 R53 |
Xi R: 38-41-53 S: (2-)26-37/39-61 |
|
|
|
603-231-00-0 |
(S)-1,1-diphenyl-1,2-propandiol |
|
443-220-6 |
— |
R52-53 |
R: 52/53 S: 22-61 |
|
|
|
603-232-00-6 |
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecan |
|
444-420-6 |
— |
R53 |
R: 53 S: 61 |
|
|
|
603-233-00-1 |
blanding af: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol |
|
444-430-0 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
603-234-00-7 |
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-en |
|
444-480-3 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)37-61 |
|
|
|
604-074-00-0 |
tetrabrombisphenol-A; 2,2′,6,6′-tetrabrom-4,4′-isopropylidendiphenol |
|
201-236-9 |
79-94-7 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
604-075-00-6 |
4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol |
|
205-426-2 |
140-66-9 |
Xi; R38-41 N; R50-53 |
Xi; N R: 38-41-50/53 S: (2-)26-37/39-60-61 |
C ≥ 20 %: Xi, N; R38-41-50/53 10 % ≤ C < 20 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
604-076-00-1 |
phenolphthalein |
|
201-004-7 |
77-09-8 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 |
T R: 45-62-68 S: 53-45 |
C ≥ 5 %: T; R45-62-68 1 % ≤ C < 5 %: T; R45-68 |
|
|
604-077-00-7 |
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol |
|
419-750-9 |
98809-58-6 |
R53 |
R: 53 S: 61 |
|
|
|
604-079-00-8 |
4,4′-(1,3-phenylen-bis(1-methylethyliden))bis-phenol |
|
428-970-4 |
13595-25-0 |
Repr.Cat.3; R62 R43 N; R51-53 |
Xn; N R: 43-62-51/53 S: (2-)22-36/37-61 |
|
|
|
604-080-00-3 |
4-fluor-3-trifluormethylphenol |
|
432-560-0 |
61721-07-1 |
Xn; R20 C; R35 R43 N; R51-53 |
C; N R: 20-35-43-51/53 S: (1/2-)26-28-36/37/39-45-61 |
|
|
|
604-081-00-9 |
1,1-bis(4-hydroxyphenyl)-1-phenylethan |
|
433-130-5 |
1571-75-1 |
N; R50-53 |
N R: 50/53 S: 25-60-61 |
|
|
|
604-082-00-4 |
2-chlor-6-fluorphenol |
E |
433-890-8 |
2040-90-6 |
Muta.Cat.2; R46 Repr.Cat.3; R62 Xn; R22 C; R34 R43 N; R51-53 |
T; N R: 46-22-34-43-62-51/53 S: 53-45-61 |
|
|
|
604-083-00-X |
4,4′-sulfonylbisphenol, polymer med ammoniumchlorid (NH4Cl), pentachlorphosphoran og phenol |
|
439-270-3 |
260408-02-4 |
R53 |
R: 53 S: 61 |
|
|
|
604-084-00-5 |
1-ethoxy-2,3-difluorbenzen |
|
441-000-4 |
121219-07-6 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)23-61 |
|
|
|
604-087-00-1 |
blanding af: 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)monoester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)diester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)triester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol |
|
433-640-8 |
— |
F; R17 R44 R53 |
F R: 17-44-53 S: (2-)15-22-61 |
|
|
|
604-089-00-2 |
2-methyl-5-tert-butylthiophenol |
|
444-970-7 |
— |
R10 Repr.Cat.3; R63 Xn; R48/20/22-65 Xi; R36/38 R43 R67 N; R50-53 |
Xn; N R: 10-36/38-43-48/20/22-63-65-67-50/53 S: (2-)26-36/37-62-60-61 |
|
|
|
605-037-00-1 |
trans-3-[2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd; 3-[(E)-2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd |
|
421-800-1 |
120578-03-2 |
R53 |
R: 53 S: 22-61 |
|
|
|
605-038-00-7 |
3-methyl-5-phenylpentan-1-al |
|
433-900-0 |
55066-49-4 |
Xn; R22 Xi; R38 R43 N; R51-53 |
Xn; N R: 22-38-43-51/53 S: (2-)36/37-61 |
|
|
|
605-039-00-2 |
3,4-dihydroxy-5-nitrobenzaldehyd |
|
441-810-8 |
116313-85-0 |
Xn; R22 Xi; R41 R43 |
Xn R: 22-41-43 S: (2-)22-24-26-37/39 |
|
|
|
606-124-00-7 |
1-cyclopropyl-3-(2-methylthio-4-trifluormethylphenyl)-1,3-propandion |
|
421-080-7 |
161462-35-7 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)36-60-61 |
|
|
|
606-125-00-2 |
1-benzylimidazolidin-2,4-dion |
|
421-340-1 |
6777-05-5 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
|
606-126-00-8 |
1,4-bis(2,3-dihydroxypropylamino)anthraquinon |
|
421-470-7 |
99788-75-7 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
606-128-00-9 |
2,2′-(1,3-phenylen)bis[5-chlor-1H-isoindol]-1,3(2H)-dion |
|
422-650-8 |
148935-94-8 |
R53 |
R: 53 S: 61 |
|
|
|
606-129-00-4 |
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-on; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-on |
|
423-090-7 |
156732-13-7 |
R53 |
R: 53 S: 61 |
|
|
|
606-130-00-X |
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanon |
|
423-860-2 |
56309-94-5 |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-61 |
|
|
|
606-131-00-5 |
cyclisk 3-(1,2-ethandiylacetal)-estra-5(10),9(11)-dien-3,17-dion |
E |
427-230-8 |
5571-36-8 |
Repr. Cat. 2; R60 Xn; R48/22 N; R51-53 |
T; N R: 60-48/22-51/53 S: 53-45-61 |
|
|
|
606-132-00-0 |
(6β)-6,19-epoxyandrost-4-en-3,17-dion |
|
433-490-3 |
6563-83-3 |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-61 |
|
|
|
606-134-00-1 |
androsta-1,4,9(11)-trien-3,17-dion |
|
433-560-3 |
15375-21-0 |
Repr. Cat.3; R62 |
Xn R: 62 S: (2-)22-36/37 |
|
|
|
606-135-00-7 |
cyclohexadecanon |
|
438-930-8 |
2550-52-9 |
R53 |
R: 53 S: 61 |
|
|
|
606-136-00-2 |
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosan-2,5,8,11,14,17,20,23-octaon |
|
444-350-6 |
133413-70-4 |
Xi; R36 R53 |
Xi R: 36-53 S: (2-)26-61 |
|
|
|
606-137-00-8 |
trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinyliden]-3,3′-dion |
|
444-750-0 |
211387-26-7 |
R53 |
R: 53 S: 22-61 |
|
|
|
606-138-00-3 |
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanon |
|
444-800-1 |
141645-23-0 |
R10 Xn; R22-48/22 Xi; R38-41 R43 N; R50-53 |
Xn; N R: 10-22-38-41-43-48/22-50/53 S: (2-)23-26-36/37/39-60-61 |
C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53 20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53 10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
606-139-00-9 |
(S)-4-(3,4-dichlorphenyl)-3,4-dihydro-2H-naphthalen-1-on |
|
444-830-5 |
124379-29-9 |
R53 |
R: 53 S: 61 |
|
|
|
606-140-00-4 |
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-on |
|
444-860-9 |
474510-57-1 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 |
|
|
|
606-141-00-X |
natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolat |
|
418-410-7 |
— |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
|
606-142-00-5 |
blanding af: (1RS,2SR,7SR,8SR,E)-9-og 10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-9-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on |
|
434-290-9 |
— |
Xn; R22 N; R51-53 |
Xn; N R: 22-51/53 S: (2-)61 |
|
|
|
607-580-00-X |
ethyl-7-chlor-1-(2,4-difluorphenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylat |
|
422-360-1 |
100491-29-0 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)22-24-37-61 |
|
|
|
607-618-00-5 |
menadionnatriumbisulfit; 2-naphthalensulfonsyre, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, natriumsalt |
|
204-987-0 |
130-37-0 |
Xi; R36/38 N; R50-53 |
Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 |
|
|
|
607-619-00-0 |
menadionnicotinamidbisulfit; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalen-2-sulfonsyre, forbindelse med nicotin-3-amid (1:1) |
|
277-543-7 |
73581-79-0 |
Xi; R36/38 N; R50-53 |
Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 |
|
|
|
607-620-00-6 |
trinatriumnitrilotriacetat |
|
225-768-6 |
5064-31-3 |
Carc. Cat. 3; R40 Xn; R22 Xi; R36 |
Xn R: 22-36-40 S: (2-)26-36/37-46 |
C ≥ 25 %: Xn; R22-36-40 20 ≤ % C < 25 %: Xn; R36-40 5 ≤ % C < 20 %: Xn; R40 |
|
|
607-621-00-1 |
milbemectin (ISO); [blanding af milbemycin A3 (CAS-nr. 51596-10-2) og milbemycin A4 (CAS-nr. 51596-11-3) (30:70)] |
|
— |
— |
Xn; R20/22 N; R50-53 |
Xn; N R: 20/22-50/53 S: (2-)46-60-61 |
C ≥ 25 %: Xn, N; R20/22-50/53 0,25 % ≤ C < 25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
|
|
607-622-00-7 |
2-ethylhexyl-2-ethylhexanoat |
|
231-057-1 |
7425-14-1 |
Repr. Cat. 3; R63 |
Xn R: 63 S: (2-)36/37 |
|
|
|
607-623-00-2 |
diisobutylphthalat |
|
201-553-2 |
84-69-5 |
Repr. Cat. 2; R61 Repr. Cat. 3; R62 |
T R: 61-62 S: 53-45 |
C ≥ 25 %: T; R61-62 5 % ≤ C < 25 %: Xn; R62 |
|
|
607-624-00-8 |
perfluoroctansulfonsyre; heptadecafluoroctan-1-sulfonsyre; [1] kaliumperfluoroctansulfonat; kaliumheptadecafluoroctan-1-sulfonat; [2] diethanolaminperfluoroctansulfonat; [3] ammoniumperfluoroctansulfonat; ammoniumheptadecafluoroctansulfonat; [4] lithiumperfluoroctansulfonat; lithiumheptadecafluoroctansulfonat [5] |
E |
217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] |
1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] |
Carc. Cat. 3; R40 Repr. Cat. 2; R61 T; R48/25 Xn; R20/22 R64 N; R51-53 |
T; N R: 61-20/22-40-48/25-64-51/53 S: 53-45-61 |
|
|
|
607-625-00-3 |
clodinafop-propargyl (ISO) |
|
— |
105512-06-9 |
Xn; R22-48/22 R43 N; R50-53. |
Xn; N R: 22-43-48/22-50/53 S: (2-)24-36/37-46-60-61 |
C ≥ 25 %: Xn, N; R22-43-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53 2,5 % ≤ C < 10 %: Xi, N; R43-51/53 0,25 % ≤ C < 2,5 %: Xi; R43-52/53 0,001 % ≤ C < 0,25 %: Xi; R43 |
|
|
607-626-00-9 |
ethyl-1-(2,4-dichlorphenyl)-5-(trichlormethyl)-1H-1,2,4-triazol-3-carboxylat |
|
401-290-5 |
103112-35-2 |
Carc.Cat.2; R45 N; R50-53 |
T; N R: 45-50/53 S: 53-45-60-61 |
|
|
|
607-627-00-4 |
[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzensulfonat |
|
416-360-0 |
162221-28-5 |
R43 |
Xi R: 43 S: (2-)22-24-37 |
|
|
|
607-628-00-X |
4-oxo-4-(p-tolyl)smørsyre, addukt med 4-ethylmorpholin |
|
419-240-6 |
171054-89-0 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
607-629-00-5 |
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]eddikesyre |
|
419-270-1 |
123599-82-6 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
|
607-630-00-0 |
acrylsyre, 3-(trimethoxysilyl)propylester |
|
419-560-6 |
4369-14-6 |
Xn; R20 C; R34 R43 R52-53 |
C R: 20-34-43-52/53 S: (1/2-)26-36/37/39-45-61 |
|
|
|
607-631-00-6 |
blanding af: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl-oxo(phenyl)acetat; (2-(2-hydroxyethoxy)ethyl)-oxo(phenyl)acetat |
|
442-300-8 |
— |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
607-632-00-1 |
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamid |
|
420-210-1 |
111244-14-5 |
R53 |
R: 53 S: 61 |
|
|
|
607-633-00-7 |
trinatrium-5-{[4-chlor-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalendisulfonat |
|
440-480-2 |
341026-59-3 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-24-26-37/39 |
|
|
|
607-634-00-2 |
(S)-(-)-2-acetoxypropionylchlorid; (1S)-2-chlor-1-methyl-2-oxoethylacetat |
|
420-610-4 |
36394-75-9 |
Xn; R22 C; R34 R43 |
C R: 22-34-43 S: (1/2-)23-26-36/37/39-45 |
|
|
|
607-635-00-8 |
trinatrium-N-(3-propionato)-L-aspartat |
|
422-090-4 |
172737-80-3 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
607-636-00-3 |
1-brom-2-methylpropylpropionat |
|
422-900-6 |
158894-67-8 |
R10 Carc.Cat.3; R40 C; R34 R43 |
C R: 10-34-40-43 S: (1/2-)7/9-8-23-26-36/37/39-45 |
|
|
|
607-637-00-9 |
dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalen-2-sulfonat |
|
423-730-5 |
250688-43-8 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
607-638-00-4 |
2-hydroxybenzoesyre-2-butyloctylester |
|
431-090-3 |
190085-41-7 |
R53 |
R: 53 S: 61 |
|
|
|
607-639-00-X |
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenylacetat |
|
431-770-1 |
216698-07-6 |
R53 |
R: 53 S: 61 |
|
|
|
607-641-00-0 |
2-(formylamino)-3-thiophencarboxylsyre; 2-formamido-3-thiophencarboxylsyre |
|
431-930-9 |
43028-69-9 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)22-24-37 |
|
|
|
607-642-00-6 |
3,6,9-trithiaundecamethylen-1,11-dimethacrylat |
|
432-210-7 |
141631-22-3 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
607-643-00-1 |
dimethyl (2S)-2-hydroxysuccinat |
|
432-310-0 |
617-55-0 |
R10 Xi; R41 R43 |
Xi R: 10-41-43 S: (2-)24-26-37/39-43 |
|
|
|
607-644-00-7 |
methyl-2,2-dimethyl-6-methylencyclohexancarboxylat |
|
432-350-9 |
81752-87-6 |
Xi; R38 |
Xi R: 38 S: (2-)37 |
|
|
|
607-645-00-2 |
tetranatrium-2-(4-fluor-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalen-1,7-disulfonat |
|
432-550-6 |
243858-01-7 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
607-646-00-8 |
D-erythro-hexansyre-2,4-dideoxy-3,5-O-(1-methylethyliden)-1,1-dimethylethylester; tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetat |
|
432-960-5 |
124655-09-0 |
Xn; R22 |
Xn R: 22 S: (2-)25 |
|
|
|
607-647-00-3 |
5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolan |
|
433-530-1 |
143446-73-5 |
Xn; R22 R43 N; R50 |
Xn; N R: 22-43-50 S: (2-)24-37-57-61 |
|
|
|
607-649-00-4 |
[3-(chlorcarbonyl)-2-methylphenyl]acetat |
|
433-690-0 |
167678-46-8 |
C; R35 R43 |
C R: 35-43 S: (1/2-)7/8-26-36/37/39-45 |
|
|
|
607-650-00-X |
2-methyl-1,5-pentandiamin-1,3-benzendicarboxylat |
|
433-910-5 |
145153-52-2 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
607-651-00-5 |
natrium-2-(nonanoyloxy)benzensulfonat |
|
434-360-9 |
91125-43-8 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
|
607-652-00-0 |
ethyl-N 2-dodecanoyl-L-argininathydrochlorid |
|
434-630-6 |
60372-77-2 |
Xi; R41 N; R50 |
Xi; N R: 41-50 S: (2-)26-39-61 |
|
|
|
607-653-00-6 |
tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalen-2-sulfonat |
|
434-840-8 |
225786-91-4 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
607-654-00-1 |
(S)-3-hydroxy-γ-butyrolacton |
|
434-990-4 |
7331-52-4 |
R43 |
Xi R: 43 S: (2-)23-24-37 |
|
|
|
607-655-00-7 |
ethyl-6,8-dichloroctanoat |
|
435-080-1 |
1070-64-0 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
|
607-656-00-2 |
natriumsalt af 4-amino-3,6-bis[[5-[[4-chlor-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalendisulfonsyre |
|
435-350-7 |
141250-43-3 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
|
607-657-00-8 |
pentanatrium-7-(4-(4-(3-(2-sulfatoethansulfonyl)phenylamino)-6-(4-(2-sulfatoethansulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat |
|
436-920-8 |
172399-10-9 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
607-658-00-3 |
3,10-diamino-6,13-dichlor-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazindisulfonsyre, lithiumkaliumnatriumsalt |
|
440-770-9 |
371921-63-0 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
|
607-659-00-9 |
pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chlor-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropansyre |
|
442-030-0 |
321912-47-4 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
607-660-00-4 |
2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalen-4,6,8-trisulfonat, trinatriumsalt |
|
442-230-8 |
321679-52-1 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
607-661-00-X |
1,1-dimethylethyl-4′-(brommethyl)biphenyl-2-carboxylat |
|
442-850-9 |
114772-40-6 |
R43 R53 |
Xi R: 43-53 S: (2-)22-24-37-61 |
|
|
|
607-662-00-5 |
methyl-2-(acetylamino)-3-chlorpropionat |
|
442-860-3 |
87333-22-0 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-60-61 |
|
|
|
607-663-00-0 |
bis(2-ethylhexyl)-naphthalen-2,6-dicarboxylat |
|
442-980-6 |
127474-91-3 |
R53 |
R: 53 S: 61 |
|
|
|
607-664-00-6 |
methyl-2-chlorsulfonyl-4-(methansulfonylaminomethyl)benzoat |
|
443-120-2 |
393509-79-0 |
Xi; R41 N; R51-53 |
Xi; N R: 41-51/53 S: (2-)26-39-61 |
|
|
|
607-665-00-1 |
trans-methyl-2-ethyl-but-2-enoat |
|
443-150-6 |
101226-85-1 |
R10 |
R: 10 S: 23 |
|
|
|
607-666-00-7 |
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansyre |
|
443-560-5 |
88784-33-2 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
|
607-667-00-2 |
chlor-1-ethylcyclohexylcarbonat |
|
444-950-8 |
99464-83-2 |
Muta.Cat.3; R68 R43 |
Xn R: 43-68 S: (2-)23-36/37 |
|
|
|
607-668-00-8 |
trans-2-isopropyl-5-carboxy-1,3-dioxan |
|
445-770-2 |
42031-28-7 |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
|
607-669-00-3 |
methyl-(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoat |
|
445-990-9 |
376588-17-9 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
607-670-00-9 |
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propylammoniumoxalat; (5-amino-2-butylbenzofuran-3-yl)-[4-(3-dibutylaminopropoxy)phenyl]methanon, dioxalat |
|
448-700-9 |
500791-70-8 |
Xn; R48/22 Xi; R41 R43 N; R50-53 |
Xn; N R: 41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 |
C ≥ 10 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
607-671-00-4 |
diethyl-1,4-cyclohexandicarboxylat |
|
417-310-0 |
72903-27-6 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
607-672-00-X |
blanding af: 2-hydroxy-3-(methacryloyloxy)propyl-(2-benzoyl)benzoat; 1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoat; x-hydroxy-y-(methacryloyloxy)propyl(eller -ethyl)-(2-benzoyl)benzoat |
|
419-000-0 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
|
607-673-00-5 |
1-ethyl-5,6,7,8-tetrahydroquinoliniumtosylat |
|
419-570-0 |
— |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)61 |
|
|
|
607-674-00-0 |
branched C10-alkyl benzoates |
|
421-090-1 |
131298-44-7 |
Xn; R20 |
Xn R: 20 S: (2-)23 |
|
|
|
607-675-00-6 |
blanding af: cis-9-octadecendisyre; cis-9-cis-12-octadecadiendisyre; hexadecandisyre; octadecandisyre |
|
422-260-8 |
— |
Xi; R41 N; R50-53 |
Xi; N R: 41-50/53 S: (2-)26-39-60-61 |
|
|
|
607-676-00-1 |
blanding af: 2-methylnonandisyre; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecandisyre; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecandisyre |
|
423-670-1 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
|
607-677-00-7 |
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinat |
|
424-660-8 |
— |
Xn; R48/22 Xi; R41 R43 |
Xn R: 41-43-48/22 S: (2-)22-26-36/37/39 |
|
|
|
607-678-00-2 |
blanding af: ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat; ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat |
|
427-090-8 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)23-25-36/37-61 |
|
|
|
607-679-00-8 |
blanding af: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetat); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat) |
|
431-440-5 |
— |
Xi; R41 N; R51-53 |
Xi; N R: 41-51/53 S: (2-)22-26-39-61 |
|
|
|
607-680-00-3 |
tert-butyl(6-{2-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetat |
|
432-810-9 |
— |
R53 |
R: 53 S: 61 |
|
|
|
607-681-00-9 |
blanding af: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecansyre; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecansyre; dihexadecyl-9-nonyl-10-octylnonadecandioat; 1-octadecyl-19-hexadecyl-9-nonyl-10-octylnonadecandioat; dioctadecyl-9-nonyl-10-octylnonadecandioat |
|
432-910-2 |
— |
R53 |
R: 53 S: 61 |
|
|
|
607-682-00-4 |
kompleks blanding af kinesisk gummiharpiks, efterfølgende behandlet med acrylsyre |
|
434-230-1 |
144413-22-9 |
R53 |
R: 53 S: 61 |
|
|
|
607-683-00-X |
blanding af: methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat; methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat (20:80) |
|
435-450-0 |
— |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
|
607-684-00-5 |
alkener, C12-14, hydroformyleringsprodukter, destillationsrester, C-(hydrogensulfobutandioater), dinatriumsalte |
|
435-660-2 |
243662-67-1 |
Xi; R38 R43 |
Xi R: 38-43 S: (2-)24-37 |
|
|
|
607-685-00-0 |
ammonium-2-cocoyloxyethansulfonat |
|
441-050-7 |
— |
Xi; R38-41 |
Xi R: 38-41 S: (2-)26-37/39 |
|
|
|
607-686-00-6 |
6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonyloxy)-6-methyl-2-phenylen]di(naphthalen-1-sulfonat) |
|
441-550-5 |
— |
E; R2 F; R11 Carc. Cat. 3; R40 |
E; Xn R: 2-11-40 S: (2-)7-22-36/37 |
|
|
|
607-687-00-1 |
blanding af: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %) |
|
442-800-6 |
— |
Xi; R38 N; R51-53 |
Xi; N R: 38-51/53 S: (2-)37-61 |
|
|
|
607-688-00-7 |
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchlorid |
|
444-320-2 |
— |
Xn; R22 |
Xn R: 22 S: (2-) |
|
|
|
607-689-00-2 |
blanding af: methyl-1,4-dimethylcyclohexancarboxylat (»para-isomer« inkl. cis-og trans-isomerer); methyl-1,3-dimethylcyclohexancarboxylat (»meta-isomer« inkl. cis-og trans-isomerer) |
|
444-920-4 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
|
607-690-00-8 |
dimethyl-[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoat |
|
432-860-1 |
255387-46-3 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
607-691-00-3 |
magnesiumsalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære |
|
448-690-6 |
— |
R53 |
R: 53 S: 61 |
|
|
|
607-692-00-9 |
zinksalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære |
|
446-470-4 |
— |
R53 |
R: 53 S: 61 |
|
|
|
607-693-00-4 |
hexyl-2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoat |
|
443-860-6 |
302776-68-7 |
R53 |
R: 53 S: 61 |
|
|
|
607-694-00-X |
ethyl-5,5-diphenyl-2-isoxazolin-3-carboxylat |
|
443-870-0 |
163520-33-0 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)22-36/37-60-61 |
|
|
|
608-042-00-7 |
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromid |
|
421-810-4 |
194602-27-2 |
Xn; R22 Xi; R41 R43 N; R51-53 |
Xn; N R: 22-41-43-51/53 S: (2-)24-26-37/39-61 |
|
|
|
608-059-00-X |
5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril |
|
421-240-6 |
120068-79-3 |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
|
608-060-00-5 |
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophencarbonitril |
|
421-300-1 |
138564-59-7 |
N; R50-53 |
N R: 50/53 S: 22-60-61 |
|
|
|
608-062-00-6 |
2-fluor-4-hydroxybenzonitril |
|
422-810-7 |
82380-18-5 |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
|
608-063-00-1 |
(S)-α-hydroxy-3-phenoxy-benzenacetonitril |
|
441-070-6 |
61826-76-4 |
T; R25 Xi; R41 R43 N; R50-53 |
T; N R: 25-41-43-50/53 S: (1/2-)9-26-36/37/39-45-60-61 |
|
|
|
608-064-00-7 |
cyanmethyltrimethylammoniummethylsulfat |
|
433-720-2 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
|
609-069-00-7 |
moskusketon; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenon; 4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenon |
|
201-328-9 |
81-14-1 |
Carc. Cat. 3; R40 N; R50-53 |
Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 |
|
|
|
611-154-00-9 |
trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalen-2,7-disulfonat |
|
403-670-6 |
92408-46-3 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
611-155-00-4 |
4,4′-oxybis(benzensulfonylazid) |
|
431-850-4 |
7456-68-0 |
E; R3 F; R11 Xn; R48/22 N; R50-53 |
E; Xn; N R: 3-11-48/22-50/53 S: (2-)14-22-33-35-36-60-61 |
|
|
|
611-156-00-X |
triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoat |
|
432-270-4 |
221354-37-6 |
Repr. Cat. 3; R62 Xn; R48/22 N; R51-53 |
Xn; N R: 48/22-62-51/53 S: (2-)36/37-61 |
|
|
|
611-157-00-5 |
benzensulfonsyre, 3,3′-(methylenbis((dihydroxyphenylen)azo))bis-, kaliumnatriumsalt; kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzensulfonat |
|
432-590-4 |
243869-48-9 |
Xi; R36 R52-53 |
Xi R: 36-52/53 S: (2-)26-61 |
|
|
|
611-158-00-0 |
reaktionsblanding af: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacetyl-diphenylmethan og 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonylchlorid og 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalensulfonylchlorid |
|
421-520-8 |
— |
F; R11 R53 |
F R: 11-53 S: (2-)3-12-16-33-61 |
|
|
|
611-159-00-6 |
dinatrium-4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalen-2,7-disulfonat |
|
421-880-6 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
|
611-160-00-1 |
blanding af: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalen-1″-sulfonato)ethan; 1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalen-1″-sulfonato)ethan; reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (2:1); reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (1:2) |
|
422-760-6 |
— |
F; R11 R53 |
F R: 11-53 S: (2-)3-12-33-61 |
|
|
|
611-161-00-7 |
trinatrium-[1,2′-(2-(8-amino-3,5-disulfonatonaphthalen)azo)-(4′-nitrobenzen)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzen)diolato-O,O,N]chromat(III) |
|
423-100-1 |
— |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
611-162-00-2 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolbis(methansulfonat) |
|
429-600-4 |
— |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
|
611-163-00-8 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolsulfat |
|
429-610-9 |
— |
Xn; R22 Xi; R41 N; R51-53 |
Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 |
|
|
|
611-164-00-3 |
blanding af: 2,2′-dimethyl-2,2′-azobutannitril; 2-methylpentannitril-2-azo-2′-(2′-methylpropannitril); 2,2′-dimethyl-2,2′-azoheptannitril; 2-methylheptannitril-2-azo-2′-(2′-methylpropannitril); 2-methylheptannitril-2-azo-2′-(2′-methylbutannitril) |
|
429-710-2 |
— |
R10 R32 R44 Xn; R22 N; R51-53 |
Xn; N R: 10-22-32-44-51/53 S: (2-)12-15-16-47-51-61 |
|
|
|
611-165-00-9 |
blanding af: tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat; tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat |
|
431-830-5 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
|
611-166-00-4 |
blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat |
|
432-100-9 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)26-39-61 |
|
|
|
611-167-00-X |
natrium-bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cuprat(II) |
|
435-240-9 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
|
611-168-00-5 |
blanding af: 3-[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chlor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre; 3,5-bis[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre |
|
435-440-6 |
— |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
611-169-00-0 |
natrium-5-(2-carboxyphenylazo)-6-hydroxynaphthalen-2-sulfonat |
|
435-800-2 |
— |
R52-53 |
R: 52/53 S: 61 |
|
|
|
611-170-00-6 |
blanding af: trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoat(5-)-κ-O)cuprat(II); dinatrium-2-((1-(5-ethensulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoat-κ-O-(5-))cuprat(II) |
|
435-880-9 |
— |
R52-53 |
R: 52/53 S: 22-61 |
|
|
|
611-171-00-1 |
blanding af: trinatrium-3-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat; trinatrium-3-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat |
|
436-890-6 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
|
611-172-00-7 |
blanding af: triammonium-6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalensulfonat; diammonium-3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoat |
|
438-310-7 |
— |
E; R2 Repr. Cat. 3; R62 Xn; R22-48/22 R52-53 |
E; Xn R: 2-22-48/22-62-52/53 S: (2-)22-35-36/37-61 |
|
|
|
611-173-00-2 |
blanding af: 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, trinatriumsalt; 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, dinatriumsalt |
|
440-510-4 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-26-36/37/39 |
|
|
|
611-174-00-8 |
blanding af: 3-[5-(4-ethensulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt; 3-[5-(4-(2-chlorethansulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt |
|
442-290-5 |
457624-86-1 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
611-175-00-3 |
blanding af: trinatrium-5-{4-chlor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; dinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; tetranatrium-5-{4-chlor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2,7-disulfonat |
|
444-050-5 |
— |
Xi; R41 R52-53 |
Xi R: 41-52/53 S: (2-)22-26-39-61 |
|
|
|
611-176-00-9 |
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester med 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonat |
|
444-250-2 |
— |
E; R2 F; R11 N; R51-53 |
E; N R: 2-11-51/53 S: (2-)22-61 |
|
|
|
611-177-00-4 |
blanding af: pentanatrium-bis[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III); tetranatrium-[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III); trinatrium-bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III) |
|
444-290-0 |
508202-43-5 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)22-24-26-37/39-61 |
|
|
|
611-178-00-X |
blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat |
|
445-280-9 |
— |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 |
|
|
|
611-179-00-5 |
blanding af: pentanatrium-2-[[8-[[4-chlor-6-[[4-(2-sulfonatoethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat; 2-[[8-[[4-chlor-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat |
|
450-010-8 |
— |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)22-24-26-37/39 |
|
|
|
611-180-00-0 |
jern, komplekser med diazoteret 4-aminobenzensulfonamid, diazoteret 3-aminobenzensulfonsyre, diazoteret 3-amino-4-hydroxybenzensulfonamid,diazoteret 3-amino-4-hydroxy-N-phenylbenzensulfonamid, diazoteret 5-amino-2-(phenylamino)benzensulfonsyre og resorcinol, natriumsalte |
|
417-850-7 |
— |
N; R51-53 |
N R: 51/53 S: 22-61 |
|
|
|
612-238-00-8 |
(3-chlor-2-hydroxypropyl)trimethylammoniumchlorid …% |
B |
222-048-3 |
3327-22-8 |
Carc. Cat. 3, R40 R52-53 |
Xn R: 40-52/53 S: 36/37-61 |
|
|
|
612-239-00-3 |
biphenyl-3,3′,4,4′-tetrayltetraamin; diaminobenzidin |
|
202-110-6 |
91-95-2 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 |
T R: 45-68 S: 53-45 |
|
|
|
612-240-00-9 |
pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)anilin |
|
— |
53112-28-0 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
612-241-00-4 |
piperazinhydrochlorid; [1] piperazindihydrochlorid; [2] piperazinphosphat [3] |
|
228-042-7 [1] 205-551-2 [2] 217-775-8 [3] |
6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] |
Repr. Cat. 3; R62-63 Xi; R36/38 R42/43 R52-53 |
Xn R: 36/38-42/43-62-63-52/53 S: (1/2-)22-36/37-45-63-61 |
|
|
|
612-242-00-X |
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amin |
|
— |
121552-61-2 |
R43 N; R50-53 |
Xi; N R: 43-50/53 S: (2-)24-37-46-60-61 |
C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
612-243-00-5 |
(1S-cis)-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamin-2-hydroxy-2-phenylacetat |
|
420-560-3 |
79617-97-3 |
Xi; R41 N; R50-53 |
Xi; N R: 41-50/53 S: (2-)26-39-60-61 |
C ≥ 10 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2, 5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
612-244-00-0 |
3-(piperazin-1-yl)-benzo[d]isothiazolhydrochlorid |
|
421-310-6 |
87691-88-1 |
Repr. Cat. 3; R62 Xn; R22 Xi; R36 R43 N; R50-53 |
Xn; N R: 22-36-43-62-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
|
612-245-00-6 |
2-ethylphenylhydrazinhydrochlorid |
|
421-460-2 |
19398-06-2 |
Carc. Cat. 3; R40 T; R48/25 Xn; R22 Xi; R41 R43 N; R50-53 |
T; N R: 22-40-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 |
C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53 10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53 5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
612-246-00-1 |
(2-chlorethyl)(3-hydroxypropyl)ammoniumchlorid |
E |
429-740-6 |
40722-80-3 |
Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/22 R43 R52-53 |
T R: 45-46-43-48/22-52/53 S: 53-45-61 |
|
|
|
612-247-00-7 |
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzencarboximidamid |
|
423-530-8 |
152828-23-4 |
T; R48/25 Xn; R22 R52-53 |
T R: 22-48/25-52/53 S: (1/2-)22-36-45-61 |
|
|
|
612-248-00-2 |
reaktionsprodukt af diphenylamin, phenothiazin og alkener, forgrenede (C8-10, C9-rige) |
|
439-540-0 |
— |
Xi; R38 R43 R53 |
Xi R: 38-43-53 S: (2-)24-37-61 |
|
|
|
612-249-00-8 |
4-[(3-chlorphenyl)(1H-imidazol-1-yl)methyl]-1,2-benzendiamindihydrochlorid |
|
425-030-5 |
159939-85-2 |
Repr. Cat. 3; R62 Xn; R22 C; R34 R43 N; R51-53 |
C; N R: 22-34-43-62-51/53 S: (1/2-)22-26-36/37/39-45-61 |
|
|
|
612-250-00-3 |
chlor-N,N-dimethylformiminiumchlorid |
E |
425-970-6 |
3724-43-4 |
R14 Repr. Cat. 2; R61 Xn; R22 C; R35 |
T; C R: 61-14-22-35 S: 53-45 |
|
|
|
612-251-00-9 |
cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantanchlorid |
|
426-020-3 |
51229-78-8 |
F; R11 Repr. Cat. 3; R63 Xn; R22 Xi; R38 R43 N; R51-53 |
F; Xn; N R: 11-22-38-43-63-51/53 S: (2-)7-22-33-36/37-61 |
|
|
|
612-252-00-4 |
imidacloprid (ISO); 1-(6-chlorpyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamin |
|
428-040-8 |
138261-41-3 |
Xn; R22 N; R50-53 |
Xn; N R: 22-50/53 S: (2-)22-57-60-61 |
|
|
|
612-253-00-X |
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende < 0,5 % formamid (EF-nr. 200-842-0)] |
|
429-400-7 |
199327-61-2 |
R52-53 |
R: R52/53 S: 61 |
|
|
|
612-253-01-7 |
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende ≥ 0,5 % formamid (EF-nr. 200-842-0) ] |
|
429-400-7 |
199327-61-2 |
Repr. Cat. 2; R61 R52-53 |
T R: 61-52/53 S: 53-45-61 |
|
|
|
612-254-00-5 |
reaktionsprodukter af diisopropanolamin med formaldehyd (1:4) |
|
432-440-8 |
220444-73-5 |
Carc. Cat. 3; R40 Xn; R22 C; R34 R43 N; R51-53 |
C; N R: 22-34-40-43-51/53 S: (1/2-)13-25-26-36/37/39-45-61 |
|
|
|
612-255-00-0 |
1-(3-methoxypropyl)-4-piperidinamin |
|
431-950-8 |
179474-79-4 |
Xn; R21/22 C; R34 R52-53 |
C R: 21/22-34-52/53 S: (1/2-)26-36/37/39-45-61 |
|
|
|
612-256-00-6 |
benzyl(S)-2-[(2′-cyanbiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrat |
|
427-470-3 |
137864-22-3 |
Xn; R22 R43 |
Xn R: 22-43 S: (2-)36/37 |
|
|
|
612-257-00-1 |
tripropylammoniumdihydrogenphosphat |
|
433-700-3 |
35687-90-2 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
|
612-259-00-2 |
N-ethyl-3-trimethoxysilyl-2-methyl-propanamin |
|
437-720-3 |
227085-51-0 |
Xi; R41 |
Xi R: 41 S: (2-)26-39 |
|
|
|
612-261-00-3 |
3,5-dichlor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)anilin |
|
441-190-9 |
121451-05-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 |
C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
612-265-00-5 |
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammoniumacetat |
|
444-360-0 |
191617-13-7 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
612-266-00-0 |
3-chlor-4-(3-fluorbenzyloxy)anilin |
|
445-590-4 |
202197-26-0 |
Muta. Cat. 3; R68 Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-48/22-68-50/53 S: (2-)22-36/37-60-61 |
|
|
|
612-267-00-6 |
bis(hydrogeneret C16-18-talgalkyl)hydroxylamin |
|
418-370-0 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)36/37-61 |
|
|
|
612-269-00-7 |
blanding af: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazol; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazol; blanding af: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin |
|
420-720-2 |
— |
R53 |
R: 53 S: 22-61 |
|
|
|
612-270-00-2 |
(S)-azetidin-2-carboxylsyre-4-cyanbenzylamidhydrochlorid |
|
433-010-2 |
— |
Xn; R22 R43 R52-53 |
Xn R: 22-43-52/53 S: (2-)22-36/37-61 |
|
|
|
612-271-00-8 |
blanding af: ethyl-2-((4-(5,6-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat; ethyl-2-((4-(6,7-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat |
|
434-970-5 |
160987-57-5 |
R53 |
R: 53 S: 61 |
|
|
|
612-272-00-3 |
ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butan-1,4-dioato(4-))jern(3+)monohydrat |
|
435-210-5 |
— |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
612-273-00-9 |
alkyl(rapsolie), bis(2-hydroxyethyl)ammoniumfluorid |
|
435-650-8 |
— |
Xn; R22 C; R35 N; R50-53 |
C; N R: 22-35-50/53 S: (1/2-)26-36/37/39-45-60-61 |
|
|
|
612-274-00-4 |
(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanolacetat |
|
445-750-3 |
— |
Xn; R22 Xi; R41 R43 R52-53 |
Xn R: 22-41-43-52/53 S: (2-)22-24-26-37/39-61 |
|
|
|
612-275-00-X |
fedtsyrer, C18-umættede, dimerer, reaktionsprodukter med 1-piperazinethanamin og tallolie |
|
447-880-6 |
206565-89-1 |
Xi; R38-41 R43 N; R50-53 |
Xi; N R: 38-41-43-50/53 S: (2-)23-26-36/37/39-60-61 |
C ≥ 20 %: Xi, N; R38-41-43-50/53 10 % ≤ C < 20 %: Xi, N; R41-43-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
612-276-00-5 |
1-amino-4-[(4-amino-2-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsyre, dinatriumsalt, reaktionsprodukter med 2-[[3-[(4,6-dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, natriumsalte |
|
451-430-4 |
500717-36-2 |
Xi; R41 R43 R52-53 |
Xi R: 41-43-52/53 S: (2-)22-24-26-36/37/39-61 |
|
|
|
612-277-00-0 |
blanding af: 4-amino-3-(4-ethensulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalen-2,7-disulfonat kalium/natrium; 4-amino-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat kalium/natrium |
|
451-440-9 |
586372-44-3 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
612-278-00-6 |
ethidiumbromid; 3,8-diamino-1-ethyl-6-phenylphenantridiniumbromid |
|
214-984-6 |
1239-45-8 |
Muta. Cat. 3; R68 T+; R26 Xn; R22 |
T+ R: 22-26-68 S: (1/2-)28-36/37-45-63 |
|
|
|
612-279-00-1 |
(R,S)-2-amino-3,3-dimethylbutanamid |
|
447-860-7 |
144177-62-8 |
Repr. Cat. 3; R62 Xn; R48/22 Xi; R36/38 R43 |
Xn R: 36/38-43-48/22-62 S: (2-)22-26-36/37 |
|
|
|
612-280-00-7 |
3-amino-9-ethylcarbazol; 9-ethylcarbazol-3-ylamin |
H |
205-057-7 |
132-32-1 |
Carc. Cat. 2; R45 |
T R: 45 S: 53-45 |
|
|
|
613-116-01-4 |
tolylfluanid (ISO); dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid; [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] |
|
211-986-9 |
731-27-1 |
Xi; R36/37/38 R43 N; R50 |
Xi; N R: 36/37/38-43-50 S: (2-)25-36/37-46-61 |
C ≥ 20 %: Xi, N; R36/37/38-43-50 2,5 % ≤ C < 20 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
|
|
613-280-00-X |
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-on; dimethylpropylenurinstof |
|
230-625-6 |
7226-23-5 |
Repr. Cat. 3; R62 Xn; R22 Xi; R41 |
Xn R: 22-41-62 S: 26-36/37/39 |
|
|
|
613-281-00-5 |
quinolin |
E |
202-051-6 |
91-22-5 |
Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R21/22 Xi; R36/38 N; R51-53 |
T; N R: 45-21/22-36/38-68-51/53 S: 53-45-61 |
|
|
|
613-282-00-0 |
triticonazol (ISO); (RS)-(E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol |
|
— |
131983-72-7 |
N; R51-53 |
N R: 51/53 S: 61 |
|
|
|
613-283-00-6 |
ketoconazol; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorphenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanon |
E |
265-667-4 |
65277-42-1 |
Repr. Cat. 2; R60 T; R25 Xn; R48/22 N; R50-53 |
T; N R: 60-25-48/22-50/53 S: 53-45-60-61 |
|
|
|
613-284-00-1 |
metconazol (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol |
|
— |
125116-23-6 |
Repr. Cat. 3; R63 Xn; R22 N; R51-53 |
Xn; N R: 22-63-51/53 S: (2-)36/37-46-61 |
|
|
|
613-285-00-7 |
1-hydroxybenzotriazol, vandfri; [1] 1-hydroxybenzotriazol, monohydrat [2] |
|
219-989-7 [1] 219-989-7 [2] |
2592-95-2 [1] 123333-53-9 [2] |
E; R2 |
E R: 2 S: 16-35 |
|
|
|
613-286-00-2 |
kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat; [indeholdende < 0,5 % N,N-dimethylformamid (EF-nr. 200-679-5)] |
|
418-260-2 |
183196-57-8 |
R43 |
Xi R: 43 S: (2-)24-37 |
|
|
|
613-286-01-X |
kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat; [indeholdende ≥ 0,5 % N,N -dimethylformamid (EF-nr. 200-679-5)] |
|
418-260-2 |
183196-57-8 |
Repr. Cat. 2; R61 R43 |
T R: 61-43 S: 53-45 |
|
|
|
613-287-00-8 |
1-(3-iod-4-aminobenzyl)-1H-1,2,4-triazol |
|
419-540-7 |
160194-26-3 |
Xn; R22 R43 N; R51-53 |
Xn; N R: 22-43-51/53 S: (2-)24-37-61 |
|
|
|
613-288-00-3 |
1,3-bis(dimethylcarbamoyl)-imidazoliumchlorid |
|
420-930-4 |
135756-61-5 |
Xn; R22 Xi; R41 R52-53 |
Xn R: 22-41-52/53 S: (2-)22-26-37/39-61 |
|
|
|
613-289-00-9 |
3-(4-chlor-2-fluor-5-methylphenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazol |
|
432-020-4 |
142623-48-1 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
613-290-00-4 |
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-onhydrochlorid |
|
432-470-1 |
189012-93-9 |
Xi; R41 R43 N; R50-53 |
Xi; N R: 41-43-50/53 S: (2-)24-26-37/39-60-61 |
|
|
|
613-291-00-X |
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-on |
|
434-820-9 |
106461-41-0 |
Xn; R48/22 N; R50-53 |
Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 |
|
|
|
613-292-00-5 |
N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazin |
|
435-010-8 |
26157-73-3 |
Muta. Cat. 3; R68 R52-53 |
Xn R: 68-52/53 S: (2-)36/37-61 |
|
|
|
613-293-00-0 |
2-(4-tert-butylphenyl)-6-cyan-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazol-7-carboxylsyre-2,6-di-tert-butyl-4-methylcyclohexylester |
|
448-050-6 |
444065-11-6 |
R53 |
R: 53 S: 61 |
|
|
|
613-294-00-6 |
2-hexyldecansyre-[4-(6-tert-butyl-7-chlor-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester |
|
448-260-8 |
379268-96-9 |
R53 |
R: 53 S: 61 |
|
|
|
613-295-00-1 |
11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepinhydrochlorid |
|
448-720-8 |
363138-44-7 |
Xn; R22 Xi; R41 R52-53 |
Xn R: 22-41-52/53 S: (2-)22-26-39-61 |
|
|
|
613-296-00-7 |
pentakalium-2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzen-1,4-disulfonat |
|
418-270-7 |
— |
R43 R52-53 |
Xi R: 43-52/53 S: (2-)24-37-47-61 |
|
|
|
613-297-00-2 |
5-(2-bromphenyl)-2-tert-butyl-2H-tetrazol |
|
420-820-6 |
— |
R10 Xn; R22 N; R51-53 |
Xn; N R: 10-22-51/53 S: (2-)16-61 |
|
|
|
613-298-00-8 |
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-on)ethylendilactat |
|
421-560-6 |
— |
Xn; R48/22 Xi; R41 N; R51-53 |
Xn; N R: 41-48/22-51/53 S: (2-)22-26-36/39-61 |
|
|
|
613-299-00-3 |
hovedkomponent 1 (isomer 1): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt; hovedkomponent 1 (isomer 2): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt; hovedkomponent 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt; hovedkomponent 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt |
|
422-610-1 |
— |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
613-300-00-7 |
1-imidazol-1-yl-octadecan-2-ol |
|
434-120-3 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
613-301-00-2 |
dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl}imidazol-4,5-dicarboxylat |
|
443-910-7 |
— |
R53 |
R: 53 S: 61 |
|
|
|
613-302-00-8 |
dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridin-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazin-2-ylamino)benzensulfonat |
|
432-980-4 |
243858-60-8 |
Xi; R41 |
Xi R: 41 S: (2-)22-26-39 |
|
|
|
613-303-00-3 |
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridin |
|
429-800-1 |
95737-68-1 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
613-304-00-9 |
5,6-dihydroxy-2,3-dihydro-1H-indoliumbromid |
|
421-170-6 |
138937-28-7 |
Xn; R22 Xi; R41 |
Xn R: 22-41 S: (2-)22-26-39 |
|
|
|
613-305-00-4 |
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazol |
|
448-630-9 |
3147-77-1 |
R53 |
R: 53 S: 61 |
|
|
|
613-306-00-X |
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethylcarbonat |
|
433-520-5 |
82911-69-1 |
Xn; R22 R43 N; R51-53 |
Xn; N R: 22-43-51/53 S: (2-)24-37-61 |
|
|
|
613-307-00-5 |
clothianidin (ISO); 3-[(2-chlor-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidin |
|
— |
210880-92-5 |
Xn; R22 N; R50-53 |
Xn; N R: 22-50/53 S: (2-)46-60-61 |
C ≥ 25 %: Xn, N; R22-50/53 2,5 % ≤ C < 25 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
613-308-00-0 |
2-amino-5-methylthiazol |
|
423-800-5 |
7305-71-7 |
Xn; R22-48/22 N; R50-53 |
Xn; N R: 22-48/22-50/53 S: (2-)22-36-60-61 |
|
|
|
613-309-00-6 |
1-methyl-3-phenyl-1-piperazin |
|
431-180-2 |
5271-27-2 |
Xn; R21/22 Xi; R38-41 R52-53 |
Xn R: 21/22-38-41-52/53 S: (2-)26-36/37/39-61 |
|
|
|
613-310-00-1 |
(-)(3S,4R)-4-(4-fluorphenyl)-3-(3,4-methylendioxy-phenoxymethyl)-N-benzylpiperidinhydrochlorid |
|
432-360-3 |
105813-13-6 |
Xn; R22 R43 N; R50-53 |
Xn; N R: 22-43-50/53 S: (2-)22-24-37-60-61 |
|
|
|
613-311-00-7 |
methyl-5-nitrophenyl-guanidin |
|
435-500-1 |
152460-07-6 |
Xn; R22 Xi; R36 R43 R52-53 |
Xn R: 22-36-43-52/53 S: (2-)22-24-26-37-61 |
|
|
|
613-312-00-2 |
2-(4-methyl-2-phenyl-1-piperazinyl)benzenmethanolmonohydrochlorid |
|
420-200-5 |
— |
Xn; R22 Xi; R41 R43 R52-53 |
Xn R: 22-41-43-52/53 S: (2-)22-26-36/37/39-61 |
|
|
|
613-313-00-8 |
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindol-1,3(2H)-dion |
|
442-780-9 |
173838-67-0 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
613-314-00-3 |
4-decyloxazolidin-2-on; 4-decyl-1,3-oxazolidin-2-on |
|
443-770-7 |
7693-82-5 |
N; R50-53 |
N R: 50/53 S: 22-24-60-61 |
|
|
|
613-315-00-9 |
tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-yliden]-3-(piperidinocarbonyl)penta-1,3-dienyliden]-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-3-carboxylat |
|
430-390-1 |
— |
Xn; R20 R52-53 |
Xn R: 20-52/53 S: (2-)25-61 |
|
|
|
613-316-00-4 |
trimethylopropan-tri(3-aziridinylpropanoat); (TAZ) |
H |
257-765-0 |
52234-82-9 |
Muta. Cat. 3; R68 Xi; R41 R43 |
Xn R: 41-43-68 S: 26-36/37/39-42 |
|
|
|
615-044-00-1 |
4-chlorphenylisocyanat |
|
203-176-9 |
104-12-1 |
T+; R26 Xn; R22 Xi; R37/38-41 R42 N; R50-53 |
T+; N R: 22-26-37/38-41-42-50/53 S: (1/2-)26-28-36/37/39-45-63-60-61 |
|
|
|
615-045-00-7 |
4,4′-methylen-bis(3-chlor-2,6-di-ethylphenylisocyanat) |
|
420-530-1 |
— |
R42/43 R53 |
Xn R: 42/43-53 S: (2-)23-24-37-45-61 |
|
|
|
616-126-00-X |
1-methyl-4-nitro-3-propyl-1H-pyrazol-5-carboxamid |
|
423-960-6 |
139756-01-7 |
Xn; R22-48/22 R52-53 |
Xn R: 22-48/22-52/53 S: (2-)22-36/37-61 |
|
|
|
616-164-00-7 |
dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid |
|
— |
149961-52-4 |
Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20 N; R50-53 |
Xn; N R: 20-40-63-50/53 S: (2-)36/37-46-60-61 |
C ≥ 25 %: Xn, N; R20-40-63-50/53 5 % ≤ C < 25 %: Xn, N; R40-63-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52-53 |
|
|
616-165-00-2 |
beflubutamid (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluor-m-tolyoxy)butyramid |
|
— |
113614-08-7 |
N; R50-53 |
N R: 50/53 S: 60-61 |
C ≥ 0,25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
|
|
616-166-00-8 |
cyazofamid (ISO); 4-chlor-2-cyan-N,N-dimethyl-5-p-tolylimidazol-1-sulfonamid |
|
— |
120116-88-3 |
N; R50-53 |
N R: 50/53 S: 60-61 |
C ≥ 2,5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51-53 0,025 % ≤ C < 0,25 %: R52/53 |
|
|
616-167-00-3 |
N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamid |
|
418-290-6 |
168612-06-4 |
Xi; R36 R43 |
Xi R: 36-43 S: (2-)24-26-37 |
|
|
|
616-168-00-9 |
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium |
|
418-440-0 |
136997-71-2 |
R43 |
Xi R: 43 S: (2-)22-24-37 |
|
|
|
616-169-00-4 |
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chlor-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorphenyl)-2-pyrazolin-5-on |
|
420-220-4 |
92771-56-7 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
616-170-00-X |
(2R)-2-amino-2-phenylacetamid |
|
420-370-0 |
6485-67-2 |
Xi; R36 R43 |
Xi R: 36-43 S: (2-)22-26-36/37 |
|
|
|
616-171-00-5 |
2-(p-chlorphenyl)glycinamid |
|
420-830-0 |
102333-75-5 |
Xi; R41 R43 |
Xi R: 41-43 S: (2-)24-26-37/39 |
|
|
|
616-172-00-0 |
N-(2,2,6,6,-tetramethyl-1-oxylpiperidin-4-yl)acetamid; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl |
|
423-840-3 |
14691-89-5 |
Xn; R22 |
Xn R: 22 S: (2-)22 |
|
|
|
616-174-00-1 |
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onhydrochlorid |
|
424-560-4 |
151257-01-1 |
Xn; R22 Xi; R36 |
Xn R: 22-36 S: (2-)22-26 |
|
|
|
616-175-00-7 |
2-(2-hexyldecyloxy)benzamid |
|
431-230-3 |
202483-62-3 |
R53 |
R: 53 S: 61 |
|
|
|
616-176-00-2 |
3-N,N-bis(methoxyethyl)aminoacetanilid |
|
432-530-7 |
24294-01-7 |
Xn; R22 R52-53 |
Xn R: 22-52/53 S: (2-)22-24-61 |
|
|
|
616-177-00-8 |
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)-amino)-phenylthio)-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-chlorphenyl)tetradecanamid; N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorphenyl]tetradecanamid |
|
432-970-1 |
217324-98-6 |
R53 |
R: 53 S: 61 |
|
|
|
616-178-00-3 |
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyan-4,6-dinitrophenyl)azo)phenyl)acetamid |
|
434-500-9 |
52583-35-4 |
R53 |
R: 53 S: 22-61 |
|
|
|
616-179-00-9 |
2-chlor-N-(4-methylphenyl)acetamid |
|
435-170-9 |
16634-82-5 |
Xi; R41 R43 N; R50-53 |
Xi; N R: 41-43-50/53 S: (2-)22-26-36/37/39-60-61 |
|
|
|
616-180-00-4 |
N,N-(dimethylamino)thioacetamidhydrochlorid |
|
435-470-1 |
27366-72-9 |
Repr. Cat. 2; R61 N; R50-53 |
T; N R: 61-50/53 S: 53-45-60-61 |
|
|
|
616-181-00-X |
4′-methyldodecan-1-sulfonanilid |
|
435-490-9 |
17417-32-2 |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
616-182-00-5 |
N′-(1,3-dimethylbutyliden)-3-hydroxy-2-naphthohydrazid |
|
435-860-1 |
214417-91-1 |
R43 N; R51-53 |
Xi; N R: 43-51/53 S: (2-)24-37-61 |
|
|
|
616-183-00-0 |
N-dodecyl-4-methoxybenzamid |
|
442-340-6 |
1854-15-5 |
R53 |
R: 53 S: 61 |
|
|
|
616-184-00-6 |
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamid |
|
442-560-2 |
105043-55-8 |
R53 |
R: 53 S: 61 |
|
|
|
616-186-00-7 |
N,N′-(2-chlor-1,4-phenylen)bis(3-oxobutanamid) |
|
443-010-4 |
53641-10-4 |
R52-53 |
R: 52/53 S: 61 |
|
|
|
616-188-00-8 |
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentansyreamid |
|
443-980-9 |
221215-20-9 |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
616-189-00-3 |
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamid |
|
444-780-4 |
452962-97-9 |
R53 |
R: 53 S: 61 |
|
|
|
616-190-00-9 |
N-decyl-4-nitrobenzamid |
|
445-880-0 |
64026-19-3 |
R53 |
R: 53 S: 61 |
|
|
|
616-191-00-4 |
2-ethyl-N-methyl-N-(3-methylphenyl)butanamid |
|
446-190-2 |
406488-30-0 |
Xn; R22 Xi; R36/38 R43 N; R51-53 |
Xn; N R: 22-36/38-43-51/53 S: (2-)24-26-37-61 |
|
|
|
616-192-00-X |
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilid |
|
448-060-0 |
727678-39-9 |
R53 |
R: 53 S: 61 |
|
|
|
616-193-00-5 |
N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamid |
|
449-940-7 |
368450-39-9 |
R53 |
R: 53 S: 61 |
|
|
|
616-194-00-0 |
2,2-diethoxy-N,N-dimethylacetamid |
|
449-950-1 |
34640-92-1 |
Xi; R36 |
Xi R: 36 S: (2-)26 |
|
|
|
616-196-00-1 |
dinatriumsalt af 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamid |
|
419-990-4 |
— |
N; R50-53 |
N R: 50/53 S: 60-61 |
|
|
|
616-197-00-7 |
blanding af: kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamidat; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamid |
|
422-500-1 |
— |
Xn; R48/22 |
Xn R: 48/22 S: (2-)22-36 |
|
|
|
616-198-00-2 |
1,3-bis[12-hydroxy-octadecamid-N-methylen]benzen |
|
423-300-7 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
616-200-00-1 |
blanding af: N,N′-ethan-1,2-diylbis(hexanamid); 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamid; N,N′-ethan-1,2-diylbis(12-hydroxyoctadecanamid) |
|
432-430-3 |
— |
R43 R53 |
Xi R: 43-53 S: (2-)24-37-61 |
|
|
|
616-201-00-7 |
12-hydroxyoctadecansyre, reaktionsprodukter med 1,3-benzendimethanamin og hexamethylendiamin |
|
432-840-2 |
220926-97-6 |
Xn; R20 R53 |
Xn R: 20-53 S: (2-)22-61 |
|
|
|
616-202-00-2 |
blanding af: 2,2′-[(3,3′-dichlor[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamid; 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamid; 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamid |
|
434-330-5 |
— |
Carc. Cat. 3; R40 R43 R53 |
Xn R: 40-43-53 S: (2-)36/37-61 |
|
|
|
616-203-00-8 |
blanding af: N-[5-[bis-(2-methoxy-ethyl)-amino]-2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)-phenyl]-acetamid; N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]-acetamid |
|
442-280-0 |
— |
R53 |
R: 53 S: 61 |
|
|
|
616-204-00-3 |
N,N″-(methylendi-4,1-phenylen)bis[N′-octylurinstof] |
|
451-060-3 |
122886-55-9 |
R53 |
R: 53 S: 61 |
|
|
|
617-022-00-7 |
blanding af: 1,2-dimethylpropylidendihydroperoxid; dimethyl-1,2-benzendicarboxylat |
|
442-480-8 |
— |
O; R7 Xn; R22 C; R34 R43 N; R51-53 |
O; C; N R: 7-22-34-43-51/53 S: (1/2-)3/7-14-26-36/37/39-45-50-61 |
|
|
|
647-017-00-5 |
laccase |
|
420-150-4 |
80498-15-3 |
R42 |
Xn R: 42 S: (2-)23-45 |
|
|
BILAG 1C
I bilag I udgår stofferne med følgende numre:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.